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ABSTRACT 
Myelination is a complex process requiring coordination of directional motility and 
an increase in Schwann cell (SC) size to generate a multi-lamellar myelin sheath. 
Regulation of actin dynamics during myelination is poorly understood. However, it 
is known that myelin thickness is related to the abundance of neuregulin1-type III 
(NRG) expressed on the axon surface. NRG binding to ErbB2/3 receptors on the 
Schwann cell surface initiates signaling cascades necessary for myelination. We 
identify cofilin1, an actin depolymerizing and severing protein, as a downstream 
target of NRG-ErbB2/3 signaling in rat SC. A five minute exposure of SCs to NRG 
triggers phosphorylation of ErbB2 with concomitant dephosphorylation, and 
activation, of cofilin, and its upstream regulators, LIM domain kinase (LIMK) and 
Slingshot-1 phosphatase (SSH). This leads to cofilin activation and recruitment to 
the leading edge of the SC plasma membrane. These changes are associated with 
rapid plasma membrane expansion yielding a 35–50% increase in SC size within 
30 minutes of NRG1 exposure. Cofilin1-deficient SCs increase phosphorylation of 
ErbB2, ERK, focal adhesion kinase, and paxillin in response to NRG, but fail to 
increase in size possibly due to stabilization of unusually long focal adhesions. 
Cofilin1-deficient SCs co-cultured with sensory neurons fail to elaborate myelin. 
Ultrastructural analysis reveals that they unsuccessfully segregate or engage 
axons and form only patchy basal lamina. After 48 hours of co-culturing with 
neurons, cofilin-deficient SCs fail to align and elongate on axons and often adhere 
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to the underlying substrate rather than to axons. We show that the 
Neurofibromatosis Type II (NF2) tumor suppressor, merlin, is an upstream 
regulator of cofilin1, and that merlin knockdown in Schwann cells inhibits their 
elaboration of normal myelin sheaths in vitro. Merlin-deficient SCs form shorter 
myelin segments in DRG neuron/SC co-cultures. Merlin-deficient Schwann cells 
have increased levels of both active Rac (Rac-GTP) and F-actin indicative of a 
stable actin cytoskeleton. Surprisingly merlin-deficient Schwann cells fail to 
dephosphorylate and activate cofilin1 in response to NRG stimulation. Inhibition of 
LIMK restores the ability of merlin-deficient SCs to activate cofilin in response to 
NRG. In developing rat sciatic nerve, merlin becomes hyper-phosphorylated at 
S518 during the time of peak myelin formation. During this time, cofilin is localized 
to the inner mesaxon, and subsequently to Schmidt-Lanterman incisures in mature 
myelin. This study: 1) identifies cofilin and its upstream regulators, LIMK and SSH, 
as end targets of a NRG-ErbB2/3 signaling pathway in Schwann cells, 2) 
demonstrates that cofilin modulates actin dynamics in Schwann cells allowing for 
motility needed to effectively engage and myelinate axons, 3) shows that merlin 
regulates NRG-ErbB2/3-cofilin-actin signaling during SC myelination to determine 
the myelin segment length. 
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CHAPTER ONE: GENERAL INTRODUCTION 
Schwann Cells 
The mammalian nervous system is divided into two physical domains:  the central 
and peripheral nervous systems (the CNS and PNS respectively). The CNS 
includes the brain, brain stem, and spinal cord, while the PNS includes all nerves 
that extend from spinal cord and innervate tissue. The functional cell of the nervous 
system is the neuron, which carry the electrical signals both from the brain to target 
tissues (efferent signals) and from tissue back to brain (afferent signals). The 
essential role of neurons is supported and regulated by cells collectively known as 
neuroglial cells. Each one of these specialized cells performs a specific task to 
keep neurons healthy and functional. These cells include ependymal cells, 
astrocytes, oligodendrocytes, and microglia within the CNS, and satellite and 
Schwann cells within the PNS. 
 
Schwann cells (SCs) are the myelinating neuroglial of the peripheral nervous 
system (Jessen and Mirsky 2005; Pereira et al., 2011). The multilamellar myelin 
sheath formed by mature SC enables the fast and efficient conduction of electric 
pulses (action potentials) down the axon (Fig. 1). Action potential conduction 
 2 
velocity is indeed slower when the myelin sheath is absent, malformed, or 
damaged as it is in de-myelinating disorders such as multiple sclerosis and the 
various charcot-marie-tooth. SCs myelinate only one domain of a single axon; in 
doing so, they define the location of the node of Ranvier where action potentials 
are potentiated down the axon in the process of salutatory conduction. SCs 
originate from the neural crest and go through several developmental stages until 
they reach their final differentiation into either myelinating or ensheathing (non-
myelinating) cells (Fig. 2). These stages include: Schwann cell precursor (SCP), 
immature Schwann cells (SC), and specifically for those SC that will myelinate, 
pro-myelinating. At birth most developing SCs are at the immature Schwann cell 
stage, ECM has been deposited, blood vessels have formed within the nerve, and 
peripheral nerves have the basic tissue structure/organization of adult nerves. At 
this stage, all immature SCs have the potential to become either myelinating or 
ensheathing SCs; this final decision is dictated by the diameter of the axon that the 
immature SC is in contact with. Those that are in contact with axons that have 
diameters larger than 1µm will myelinate, and those in contact with diameters 
smaller than 1 µm will ensheath. A few days after birth myelination (the process of 
expanding, wrapping, and compacting the adaxonal membrane) begins. 
 
Peripheral Myelination 
The myelin sheath, or simply myelin, is a multilamellar structure composed of a 
complex yet highly ordered mixture of lipids and proteins. Myelin-specific lipids and 
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proteins are only synthesized by a SC once two events occur (Simons and Trotter 
2007). The first event is the establishment of a one-to-one relationship between 
the SC and the domain of axolemma (the axonal cell membrane of a neuron) that 
it will myelinate (the “pro-myelinating” stage). The second event is the deposition 
of extracellular matrix (ECM), specifically laminin, surrounding the SC. After these 
two events, the SC becomes polarized and two distinct domains of the SC plasma 
membrane are created: the abaxonal membrane, the outer membrane that 
touches the ECM, and the adaxonal membrane, the inner membrane that touches 
the axolemma. Genes that encode myelin proteins are turned on by transcription 
factors that are regulated by external signaling molecules active at each of these 
membranes. There are many transcription factors necessary for the production of 
myelin (including Sox10 and Oct6 (Jagalur et al, 2011), but Krox20 is the “master” 
transcription factor essential to upregulate myelin proteins, specifically protein zero 
(P0) and myelin basic protein (MBP) (Mirsky et al., 2008). Both of these structural 
proteins function to compact and hold the multiple layers of membrane within the 
myelin together. Although P0 is the major protein component of peripheral myelin 
(Giese et al., 1992), it is expressed at a lower level at early stages of development 
before the final differentiation of SCs, while MBP is specifically expressed by 
myelinating SCs and is typically used to distinguish fully differentiated SCs.  
 
Signaling at both the abaxonal and adaxonal membranes control the development 
of SCs (Fig. 3). Specifically, at the abaxonal membrane, laminin within the ECM 
signals through integrins stimulating the activities of both FAK and the Rho family 
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of GTPases (RhoA, cdc42, and Rac), which in turn cause a reorganization of the 
actin cytoskeleton. However, at the adaxonal membrane the crucial external 
signaling molecule controlling the differentiation of SCs is neuregulin1-typeIII 
(NRG), which is expressed by neurons and anchored in the axolemma (Michailov 
et al., 2004; Taveggia et al., 2005). NRG activates the receptor tyrosine kinases 
ErbB2/ErbB3 expressed in the adaxonal membrane of the SC, initiating a 
multifaceted signaling cascade that causes expression and nuclear localization of 
Krox20. The thickness of the myelin sheath is directly proportional to the diameter 
of the axon and to the amount of NRG on the axolemma, and therefore, the amount 
of activation of the ErbB2/ErbB3 receptors. The signaling events at both the 
abaxonal and adaxonal membranes fine tune the expression of myelin genes and 
organization of the cytoskeleton in a highly-coordinated process that ultimately 
results in the production of the complex structure that is myelin. 
 
Cell Migration and Cofilin 
Cell migration occurs in a cycle in which the actin cytoskeleton provides not only 
the necessary internal cellular structure but also the force needed for the cell to 
migrate. In general, this cycle includes four steps:  initial protrusion of the 
membrane in the direction of migration, attachment of the newly formed protrusion 
to the substratum, generation of traction force, and retraction of the tail end of the 
cell (Bravo-Cordero et al., 2013). During this cycle the actin cytoskeleton is 
dynamically reorganized undergoing repeated cycles of depolymerization and 
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polymerization, especially at the leading edge and tail. The tightly regulated spatial 
and temporal pattern of events is controlled by a plethora of actin-binding proteins 
involved at each step of the migration cycle. These proteins either anchor the 
cytoskeleton (integral membrane cell adhesion molecules along with intracellular 
scaffold proteins), provide the motor force to push the cell (myosin), or facilitate 
the depolymerization (for example gelsolin or ADF/cofilin) and polymerization (for 
example WASp, ARP2/3, profilin) of the cytoskeleton itself. 
 
During the first step of the migration cycle, the ADF/cofilin protein family functions 
to initially depolymerize actin at the leading edge of cell allowing for an asymmetric 
polymerization/branching here that causes membrane protrusion (Bravo-Cordero 
et al., 2013). This protein family consists of ADF (actin depolymerizing factor), 
cofilin 1, and cofilin 2. Cofilin 1 (cofilin) is the most abundant and ubiquitous 
member of the family in vertebrate non-muscle tissues. Cofilin severs F-actin at 
the junction between cofilin-decorated and undecorated regions of F-actin by 
disrupting the non-covalent bonds between individual actin molecules. The 
severing activity of cofilin functions to one, create new sites along established F-
actin strands where branching will occur (i.e., new nucleation sites), and two, 
replenish the pool of G-actin that will be incorporated to the new growing branches 
of F-actin (Fig. 4). The localized branching and expansion of cortical actin causes 
protrusion of the plasma membrane at the leading of edge initiating cellular 
migration. 
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Cofilin’s activity is controlled in several manners including local changes in pH and 
binding to PIP2 in the plasma membrane. The best characterized regulation of 
cofilin is by phosphorylation of serine 3. Phosphorylation of serine 3 prevents cofilin 
from binding all forms of actin and this phosphorylation is performed by LIM-
domain kinase (LIMK). The major phosphatase that actives cofilin at the leading 
edge is Slingshot (SSH). Both LIMK and SSH themselves are regulated by 
phosphorylation as well. Both enzymes are phosphorylated by p21-activated 
kinase (PAK) downstream of Rac. However, phosphorylation has opposite effects 
on these two cofilin regulating enzymes: phosphorylation of LIMK stimulates its 
kinase activity, while phosphorylation of SSH inhibits its phosphatase activity. 
 
Neurofibromatosis Type II and Merlin 
Neurofibromatosis Type II (NF2) is a genetic disorder that predisposes individuals 
to formation of multiple types of nervous system tumors (Petrilli and Fernandez-
Valle 2016). These tumors include meningiomas, ependymomas, and 
schwannomas. The hallmark of the disease is bilateral formation of schwannomas 
on the eighth cranial nerve, which can cause dizziness, tinnitus, and hearing loss 
and ultimately deafness. Symptoms typically first appear in the late teens to early 
twenties with the incidence of 1 in 25,000. Although NF2 is dominantly inherited, 
50–60% of cases arise from de novo mutations and can result in sporadic 
schwannomas. 
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NF2 is caused by mutations in the Nf2 gene that encodes a tumor suppressor 
termed merlin, also known as schwannomin. Merlin is a member of the Band 4.1 
FERM gene family (merlin is an acronym for moesin, ezrin, radixin-like protein). 
The proteins within this gene family link integral plasma membrane proteins to the 
actin cytoskeleton and exhibit a similar conformation: a N-terminal, tri-lobe 
cloverleaf FERM (4.1, ezrin, radixin, moesin) domain, a central –helical domain, 
and a c-terminal actin-binding domain (Fehon et al., 2010). The activity of ezrin, 
radixin, and moesin (ERM proteins) is regulated by the intramolecular interaction 
of the N-terminus with the C-terminus, a head-to-tail interaction. This interaction is 
controlled by the phosphorylation of a c-terminal threonine, which disrupts the 
head-to-tail interaction causing the proteins to become active and “open” allowing 
them to bind with plasma membrane proteins and the actin cytoskeleton. Merlin, 
however, is unique within the family, not only because it lacks the actin-binding 
domain, but it’s activity is actually inhibited by phosphorylation of the c-terminal 
serine 518 (Petrilli and Fernandez-Valle 2016). 
 
Merlin regulates many signaling pathways controlling cell proliferation and survival 
that include receptor tyrosine kinase (RTK), cell adhesion, mammalian target of 
rapamycin (mTOR), PI3K/Akt and hippo pathways, and the nuclear-localized E3 
ubiquitin ligase (Petrilli and Fernandez-Valle 2016). One of the earliest identified 
functions of merlin is its ability to inhibit the small GTPase Rac (Morrison et al., 
2007) and its effector proteins the p21-activated kinases (PAK) (Kissil et al., 2003). 
Through this inhibition merlin indirectly regulates the actin cytoskeleton. 
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Gap in Knowledge 
In coordination with the production of myelin proteins and new membrane, NRG 
signaling at the adaxonal membrane and laminin signaling at the abaxonal 
membrane also causes a restructuring of the SC actin cytoskeleton during 
myelination. This restructuring is a cyclic process of actin depolymerization 
followed by polymerization that creates new, branched actin filaments at the 
portion of the adaxonal membrane closest to the axolemma called the inner 
mesaxon. This process is comparable to cell migration models, and the inner 
measaxon is analogous with the leading edge of migrating cells. The growing actin 
filaments effectively push the expanding adaxonal membrane at the inner 
mesaxon around the axon finally giving rise to the characteristic multi-layered 
myelin sheath. 
 
As in other cell types, the process of actin dynamics in SCs is governed by actin-
regulating proteins that either promote the disassembly or assembly of actin 
filaments. Many studies have focused on the role of proteins that promote 
assembly of actin filaments, namely N-WASp (Jin et al., 2011; Novak et al., 2011), 
and profilin (Montani et al., 2014) in myelinating SCs. What is lacking in the 
literature are studies in myelinating SCs investigating the function, as well as 
upstream regulation, of actin depolymerizing proteins, such as gelsolin or 
ADF/cofilin. 
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Figures 
 
Figure 1. Illustration of a myelinated PNS axon.  
“Schwann cells in the peripheral nervous system (PNS), form the myelin sheath by 
enwrapping their membrane several times around the axon. Myelin covers the axon at 
intervals (internodes), leaving bare gaps — the nodes of Ranvier.” Adapted from “The 
local differentiation of myelinated axons at nodes of ranvier,” by S. Poliak and E. Peles, 
2003, Nature Reviews Neuroscience, 4(12), p.968-80. 
 
 
Figure 2. The development of Schwann cells.  
“Schematic illustration of the main cell types and developmental transitions involved in 
Schwann cell development. Dashed arrows indicate the reversibility of the final, largely 
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Other differences between the three main stages of 
embryonic Schwann cell development, also shown in 
FIG. 4, include the following. First, SCPs and immature 
Schwann cells, but not migrating neural crest cells, are 
intimately associated with neurons (axons), a charac-
teristic attribute of glial cells (FIGS 2,5). Second, SCPs 
and migrating neural crest cells show numerous differ-
ences in their responses to survival factors4,15,27. Third, 
when compared with migrating neural crest cells, SCPs 
are also relatively insensitive to the neurogenic action 
of bone morphogenetic protein 2 (BMP2), and are 
strongly biased towards Schwann cell generation28,29.
Additional differences between immature Schwann 
cells and SCPs include the presence of a basal lamina, 
which starts to form soon after Schwann cells are gener-
ated (A. Kumar, R.M. and K.R.J., unpublished observa-
tions). But perhaps the most striking difference between 
these cells is the ability of Schwann cells to ensure their 
own survival through the help of autocrine survival 
circuits30. These are missing in SCPs, leaving these cells 
wholly dependent on survival signals from axons, which 
are probably mediated to a large extent by b-neuregulin 
1 (NRG1; see BOX 3 and below).
The cont rol of  gliogenesis f rom the neural crest
It has been suggested that in the CNS, glial differentia-
tion represents a ‘default pathway’ of neural stem cell 
differentiation12,13. We do not yet know whether this is 
a useful way of thinking about glial cell development in 
the PNS. However, the functions of the major signalling 
pathways that have been implicated in the control of 
gliogenesis from the neural crest — those that involve 
NRG1, BMP2 and 4, and Notch — are consistent with 
a default mode. This is because the most obvious func-
tions of these signals in the neural crest are to suppress 
glial development, or to suppress or activate neuronal 
development31–33. It has been hard to prove that these 
factors positively initiate glial differentiation from 
neural crest cells. Similarly, although the transcription 
factor SOX10 is required for glial development, it is 
expressed by all neural crest cells and therefore does 
not seem to be part of a classical inductive signalling 
cascade for the activation of glial development34.
A default model would also provide a relatively sim-
ple hypothesis explaining how, during gangliogenesis, 
neurons and glia could form in the same location. It 
would be sufficient to envisage neurogenic signals acting 
on neural crest cells, tempered by signals from early 
neurons (for example, NRG1 or Delta–Notch signalling; 
see below) that suppress excessive neurogenesis in 
neighbouring cells.
SOX10. Before investigating the often uncertain func-
tion of cell–cell signals in the initiation of glial devel-
opment, we discuss the transcription factor SOX10, 
because Sox10 is the only gene known to be essential for 
the generation of the glial lineage from trunk crest cells. 
SOX10 appears to be present in all migrating neural 
crest cells34,35. Expression persists in developing satellite 
glia in dorsal root sensory ganglia (DRG) and in SCPs 
in spinal nerves, but is downregulated in early neu-
rons. Matching this pattern, satellite glia and SCPs are 
missing in mice in which Sox10 is inactivated, whereas 
neurons are initially generated in normal numbers34. 
In these mutants, early DRGs contain neural crest-like 
cells instead of BFABP+ satellite cells (FIG. 4), and nerve 
trunks also contain a few neural crest-like cells that lack 
BFABP+. This indicates that in the absence of SOX10 
glial specification is blocked, whereas neural crest cells 
thrive and are able to generate neurons. In vitro experi-
ments also support a role for SOX10 in establishing 
Figure 1 | The Schwann cell lineage. Schematic illustration of the main cell types and 
developmental transitions involved in Schwann cell development. Dashed arrows indicate the 
reversibility of the final, largely postnatal transition during which mature myelinating and non-
myelinating cells are generated. The embryonic phase of Schwann cell development involves 
three transient cell populations. First, migrating neural crest cells, which are discussed further 
in BOX 1. Second, Schwann cell precursors (SCPs). These cells express various differentiation 
markers that are not found in migrating neural crest cells, including brain fatty acid-binding 
protein (BFABP), protein zero (P0) and desert hedgehog (DHH) (FIG. 4). At any one time, 
a rapidly developing population of cells — such as the glia of embryonic nerves — will contain 
some cells that are rather more advanced than others. However, the cells23 isolated from 
embryonic day (E) 14 rat nerves by the P07 monoclonal P0 antibody97 (referred to as ‘neural 
crest stem cells’23) are unlikely to be significantly different from the bulk of cells in the nerve, 
which are referred to here as SCPs (for a detailed discussion, see REFS 98,99). Third, immature 
Schwann cells. All immature Schwann cells are considered to have the same developmental 
potential, and their fate is determined by the axons with which they associate. Myelination 
occurs only in Schwann cells that by chance envelop large diameter axons — Schwann cells 
that ensheath small diameter axons progress to become mature non-myelinating cells.
Box 2 | Gl ial  cel ls of  the per ipheral nervous system
The PNS contains a number of distinct glial cells, each of which is intimately 
associated with different parts of the neuron or with specific neuronal cell types94.  
Neuronal cell bodies in dorsal root sensory ganglia and in sympathetic and 
parasympathetic ganglia are covered by flattened sheet-like cells known as satellite 
cells, whereas axons in nerve trunks are ensheathed by non-myelinating or 
myelinating Schwann cells, the best known of all peripheral glia. Unlike 
oligodendrocytes, the myelinating cells of the CNS, each Schwann cell forms myelin 
around one axon only. For reasons that are not understood, only the larger diameter 
(>~1 mm) axons of peripheral nerves are myelinated — smaller axons lie in troughs 
in the surface of non-myelinating Schwann cells. Distinct cells known as olfactory 
ensheathing cells envelop the axons of the olfactory nerve. Axon terminals at the 
skeletal neuromuscular junction are tightly covered by terminal glia (teloglia), 
whereas the terminals of autonomic neurons show only irregular associations with 
processes of non-myelinating Schwann cells. Many sensory nerve endings in the skin 
associate with glial cells that form the innermost part of larger structures, for 
example, the Pacinian corpuscle. Lastly, the complex ganglia of the enteric nervous 
system harbour glial cells, the enteric glia, that are remarkably similar to astrocytes.
NATURE REVIEWS | NEUROSCIENCE  VOLUM E 6 | SEPTEM BER 2005 | 673
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postnatal transition during which mature myelinating and non- myelinating cells are 
generated. The embryonic phase of Schwann cell development involves three transient 
cell populations. First, migrating neural crest cells…second, Schwann cell precursors 
(SCPs)…At any one time, a rapidly developing population of cells — such as the glia of 
embryonic nerves — will contain some cells that are rather more advanced than 
others...Third, immature Schwann cells. All immature Schwann cells are considered to 
have the same developmental potential, and their fate is determined by the axons with 
which they associate. Myelination occurs only in Schwann cells that by chance envelop 
large diameter axons — Schwann cells that ensheath small diameter axons progress to 
become mature non-myelinating cells.” Adapted from “The origin and development of glial 
cells in peripheral nerves,” by K. R. Jessen and R. Mirsky, Nature Reviews Neuroscience, 
6(9), p. 671-82. 
 
 
Figure 3. Molecular mechanisms controlling Schwann cell myelination.  
“(A) Control of PNS myelination by SC–axon interactions. SC myelination is a process 
strongly dependent on instructive signals provided by the axons. Well-known mediators of 
this interaction, together with activated signaling pathways and their influences on 
myelination are shown. Arguably the most prominent axonal signal regulating myelination 
is NRG1, which induces a multitude of different responses through several stages of SC 
maturation and in myelination. Membrane-bound NRG1-III appears to play a dominant 
role in axon–SC signaling via a juxtacrine mechanism. (B) SC-intrinsic polarization 
mechanisms involved in myelination. Multiple pathways that contain SC-intrinsic 
polarization regulators and their crucial influence on different steps of myelination are 
shown. Adapted from “Molecular mechanisms regulating myelination in the peripheral 
nervous system,” by J. A. Pereira et al., 2012, Trends in Neuroscience, 35(2), p. 123-34. 
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Figure 4. Diagram of cofilin function.  
“Cofilin severs and depolymerizes actin filaments at the base of the lamellipodium, thereby 
supplying G-actin monomers for steady-state actin polymerization in conditions of G-actin 
depletion. Dendritic nucleation is mediated by the actin-related protein 2/3 (ARP2/3) 
complex. Adapted from “Functions of cofilin in cell locomotion and invasion,” by J. J. 
Bravo-Cordero et al., 2013, Nature Reviews Molecular Cell Biology, 14(7), p. 405-15. 
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CHAPTER TWO: COFILIN IS DOWNSTREAM OF NEUREGULIN 
SINGALING AND IS ESSENTIAL FOR SCHWANN CELL 
MYELINATIOIN 
Introduction 
Myelination is a highly specialized form of cell motility in which protrusive 
expansion of the leading edge of the inner mesaxon, accompanied by high rates 
of membrane synthesis, drives the glial membrane repeatedly around the axon to 
generate the myelin sheath. The hypothesis that movement of the leading edges 
in cell motility and myelination involve similar mechanisms is supported by 
experiments from the author showing a requirement for actin polymerization in 
myelination (Fernandez-Valle et al., 1997). This idea is supported by the essential 
role of Rho GTPases, molecular switches that regulate actin dynamics during cell 
motility, in myelination (Hall, 2005; Nodari et al., 2007). 
 
A plethora of signaling pathways controlling actin polymerization have been 
identified in motile processes ranging from chemotaxis to growth cone path finding 
(von Philipsborn and Bastmeyer, 2007). However, the pathways linking axon 
contact to expansion of the Schwann cell (SC) or oligodendrocyte leading edge 
have not been elucidated. Key molecules directly regulating actin dynamics and 
organization include cofilin and actin- depolymerizing factor (ADF), also known as 
destrin (Oser and Condeelis, 2009). These proteins sever and depolymerize actin 
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filaments to generate new barbed ends to initiate actin polymerization. Although 
the activities of cofilin and ADF are similar and the proteins are often coexpressed 
in cells, they have significant functional and regulatory differences (Bernstein and 
Bamburg, 2010). 
 
Cofilin1, the major form expressed in nonmuscle cells, is regulated in several ways; 
the best characterized is phosphorylation on serine 3 (pS3-cofilin1) that inhibits its 
F-actin activity (Huang et al., 2006). LIM kinases (LIMKs) 1 and 2, and the related 
testis kinase phosphorylate cofilin1 S3. LIMKs are serine/threonine kinases 
containing two LIM (Lin-11, Isl-1, and Mec3) domains and a PDZ domain. They 
are activated by phosphorylation on T505/508 by p21-activated kinase (PAK1 and 
4) downstream of Cdc42 and Rac (Edwards et al., 1999; Dan et al., 2001), and by 
Rho-dependent kinase (ROCK) (Ohashi et al., 2000). Cofilin1 activity is also 
inhibited by binding phosphatidylinositol 4,5-bisphosphate (PIP2) at the plasma 
membrane (Yonezawa et al., 1990) and the scaffold protein 14-3-3 (Gohla and 
Bokoch, 2002). Stimulation of cofilin1 activity by dephosphorylation of serine 3 is 
conducted by Slingshot1 (SSH1) (Niwa et al., 2002) and chronophin phosphatases 
(Gohla et al., 2005). Previous studies revealed a role for pS3-cofilin1 in 
phospholipid signaling (Han et al., 2007; Bernstein and Bamburg, 2010). 
Therefore, both the phosphorylated and dephosphorylated forms of cofilin1 have 
potential functional activities in SCs. 
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A key molecule controlling myelination is neuregulin-1 (NRG1)-type III. Myelin 
thickness is influenced by the amount of NRG1-type III expressed on the axon’s 
surface (Michailov et al., 2004; Taveggia et al., 2005). This membrane-anchored 
NRG1 isoform activates ErbB3/ ErbB2 receptors that likely regulate SC motility 
around the axon, in addition to SC precursor survival and proliferation (Birchmeier 
and Nave, 2008). 
 
Here we report that cofilin1 is activated downstream of NRG1 signaling. Isolated 
cofilin1- deficient SCs activate NRG1 and laminin (LAM) signaling pathways, 
proliferate normally, assume a bipolar phenotype, and form focal adhesions. 
However, when co-cultured with sensory neurons, cofilin1-deficient SCs fail to 
effectively engage or align on axons, assemble a typical basal lamina, or produce 
myelin. 
 
Materials And Methods 
Materials And Antibodies 
Mission shRNAi lentiviral transduction particles targeting mouse cofilin1, control 
TurboGFP and nontarget shRNAi transduction particles, and puromycin were 
purchased from Sigma-Aldrich. 2.5S nerve growth factor (NGF) was purchased 
from Harlan. AG825 (C19H15N3O3S2) was purchased from Calbiochem 
(manufactured by EMD) and dissolved in DMSO. Recombinant human NRG1-β1-
ECD (neuregulin 1-beta 1 extracelluar domain; referred to as NRG1) was 
 15 
purchased from R & D Systems and dissolved in in PBS with 0.2% BSA (fatty acid 
free; Sigma-Aldrich) to yield a 100 μg/ml stock solution. Reagents and antibodies 
for the following proteins were purchased from these sources: mouse 
neurofilament-H (SMI-31 and SMI-32), vinculin (hVIN-1), destrin (ADF), integrin 
α1, integrin β 4, collagen type IV (CTIV), and chicken neurofilament-H from Abcam; 
S100 from Dako; cofilin1 and pS3-cofilin1 from Novus Biologicals; pT505/508-
LIMK1/2 and integrin α6 from Cell Signaling Technology; LIMK2 and laminin from 
Sigma-Aldrich; slingshot-1L and pS978 slingshot-1L from ECM Biosciences; Krox-
20/Egr2 and myelin basic protein (MBP) from Covance; ErbB2, pY1248-ErbB2, 
ERK1, and pT204ERK from Santa Cruz Biotechnology; DAPI, myelin-associated 
glycoprotein (MAG), pY576 focal adhesion (FA) kinase (FAK), pY118 paxillin, 
Alexa Fluor-conjugated secondary antibodies, and Alexa Fluor 633-phalloidin from 
Invitrogen; paxillin, N-cadherin, FAK, and integrin β1 from BD Biosciences; and 
GAPDH from Millipore. All cell culture reagents were purchased from Invitrogen 
except for pituitary extract, purchased from Biomedical Technologies, Inc. (bti), 
and fetal bovine serum (FBS), purchased from Atlanta Biologicals. The LIMK 
inhibitor BMS-5 (C17H14Cl2F2N4OS) was purchased from Synkinase. 
 
Preparation Of Primary Rat SCs 
Primary rat (Rattus norvegicus) SCs were isolated from sciatic nerves of 1-d-old 
Sprague Dawley (Charles River Laboratories) pups of both sexes using the 
Brockes method (Brockes et al., 1979) with modifications described previously 
(Thaxton et al., 2011). Purified rat SCs were routinely cultured at 37°C and 5% 
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CO2 on 200 μg/ml poly-L-lysine (PLL)-coated (Sigma-Aldrich) dishes (Corning) in 
D10M [DMEM supplemented with 10% heat- inactivated FBS (HIFBS), 15 μM 
forskolin (Sigma-Aldrich), 20 μg/ml bovine pituitary extract, and 
penicillin/streptomycin (P/S; Invitrogen)]. 
 
Generation Of Cofilin1-Deficient Schwann Cell Lines 
Freshly harvested and purified rat SCs were plated onto PLL-coated (200 μg/ml) 
six-well dishes, cultured in D10M, and maintained at 37°C and 5% CO2. When the 
cultures reached 70–80% confluency, lentiviral transduction particles expressing 
various cofilin1 shRNAi were added at various multiplicities of infection (MOIs) 
ranging from 0.5 to 10 in D10M plus 8 μg/ml hexadimethrine bromide (Sigma-
Aldrich). After 18–20 h, the infection medium was replaced with fresh D10M for 24 
h. D10M was then replaced with D10M containing 1 μg/ml puromycin (Sigma-
Aldrich) for the selection of transduced cells. SCs were maintained in D10M plus 
puromycin and passaged (1:3 split) to expand the populations. During expansion, 
the cofilin1 expression level was assessed by extracting SCs directly in SDS-
PAGE sample buffer and conducting Western blot analysis. ShRNAi target 94 was 
found to be the most efficient in reducing cofilin1 levels and was used to generate 
several independently derived SC lines (SC-94). SCs expressing scrambled (SCR) 
shRNAi did not consistently grow well. Therefore, SCs expressing shRNAi target 
97 (SC-97) were used in most experiments to control for the effects of lentiviral 
transduction, puromycin selection, and passage number. SC-97 cells remained 
functional as long as cofilin1 expression dropped by no more than 30% of normal 
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levels and cells were passaged no more than 10 times. The presence of puromycin 
in the culture medium had the added benefit of eliminating fibroblasts. Independent 
SC lines were created on seven different occasions with different batches of 
lentiviral transduction particles. The degree of cofilin1 knockdown and cell function 
obtained with each target shRNAi was similar each time. 
 
Preparation Of Dissociated Rat DRG Neuron/SC Co-cultures 
Dorsal root ganglia (DRGs) were harvested from Sprague Dawley rat (Charles 
River Laboratories) embryos at 17 d of gestation [embryonic day 17 (E17)] and 
were dissociated as described previously (Thaxton et al., 2011). Dissociated DRG 
neurons (DRGNs) were plated on PLL (200 μg/ml) plus laminin (50 μg/ml; 
Invitrogen) or PLL plus collagen-coated (3.4 mg/ml, type I; BD Biosciences) 12 mm 
German glass coverslips (Carolina Biological) in CB5 medium (MEM, 0.4% 
glucose, 50 ng/ml 2.5S NGF and 5% HIFBS). For myelination assays, dissociated 
DRGN cultures were seeded with primary rat SCs or cofilin1-deficient SCs at 2 × 
105 SCs per coverslip in CB10 medium (CB with 10% HIFBS). Co-cultures were 
then switched to myelin-permissive medium (CB with 15% HIFBS plus 0.05 mg/ml 
L-ascorbic acid) and were fixed 10–14 d later for ultrastructural analysis, 
immunostaining, or Sudan black staining. 
 
NRG1 Stimulation And Western Blot Analysis 
Normal [wild-type (WT)] SCs and cofilin1-deficient SC lines were plated on PLL-
coated (200 μg/ml) six-well dishes and were grown in D10M to 50–60% confluency 
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(typically 72– 96 h after plating). Cultures were starved of serum and mitogens by 
rinsing twice in warmed HBSS (Invitrogen) and incubating in D0.5 (DMEM plus P/S 
plus 0.5% HIFBS). Eighteen to 22 h later, duplicate wells were stimulated for the 
indicated times at 37°C and 5% CO2 with D0.5 plus NRG1 carrier (PBS plus 0.02% 
BSA; mock medium) or D0.5 plus 10–25 ng/ml NRG1-ECD (NRG medium). For 
the AG825 inhibitor treatment, starved cultures were preincubated with AG825 (10 
μM) in D0.5 for 1 h at 37°C and 5% CO2 and stimulated in the presence of the 
inhibitor. Following stimulation, wells were washed twice in PBS (Invitrogen) with 
phosphatase inhibitors (PIC3; Sigma-Aldrich) and were extracted directly in SDS 
sample buffer (Fermentas). Equal sample volumes were loaded on 4–20% precast 
(Pierce) or 10% self-cast polyacrylamide gels and transferred to Immobilon-P 
membranes (Millipore). HRP-conjugated goat secondary antibodies (Jackson 
ImmunoResearch) and SuperSignal West Pico Chemiluminescent Substrate 
(Pierce) were used for detection. Western blots were quantified using Carestream 
Molecular Imaging software (version 5.0). The net intensity of equivalent-sized 
regions of interest for phosphorylated and total proteins was obtained and 
normalized to GAPDH. Statistical analysis was performed from four independent 
experiments with GraphPad Prism 5. Stimulation experiments were analyzed 
using two-way ANOVA and Bonferroni’s multiple comparison test. Stimulation 
experiments using the AG825 inhibitor were analyzed using one-way ANOVA and 
Tukey’s multiple comparison test. We found that multiple factors influenced the 
consistency of the amount of phosphorylation changes. These included cell 
confluency, passage number, length of the starvation period, and activity of NRG1. 
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The activity of the NRG1 was titered before use and stored no longer than 2–3 
weeks after reconstitution of the lyophilized compound. The strongest responses 
were observed with SC cultures at no more than 60% confluency, passaged no 
more than five times (1:3 splits), and starved for a minimum of 20 h. Nonstimulated 
WT SCs and cofilin1-deficient lines were seeded on six-well dishes coated with 
PLL (200 μg/ml) or PLL (200 μg/ml) plus LAM (25 μg/ml) and were grown to 60– 
70% confluency in D10M. Proteins were extracted in chilled TAN buffer (10 mM 
Tris- acetate, 1% IGEPAL, and 100 mM NaCl, with a mixture of inhibitors) following 
two washes in chilled PBS on ice. Three to 5 μg of total protein was loaded on 4–
20% precast polyacrylamide gels (Pierce) and transferred to Immobilon-FL 
membranes (Millipore). Odyssey blocking buffer (LI-COR Biosciences), and 
secondary IRDye antibodies (LI-COR Biosciences) were used, and membranes 
were scanned and quantified using LI-COR Odyssey scanner and software. 
 
Immunofluorescence Staining Of Cultures 
WT-SC, SC-94, and SC-97 cultures and DRGN/SC co-cultures were 
immunostained as described previously (Thaxton et al., 2007). After fixation with 
4% paraformaldehyde in 0.1 M phosphate buffer, myelinating co-cultures were 
acetone treated at −20°C with sequential exposure to 50%/100%/50% acetone for 
5 min each. They were rehydrated in 0.1 M phosphate buffer and blocked for 1 h 
in block buffer: 0.1 M phosphate buffer plus 10% normal goat serum (Invitrogen). 
Myelinating co-cultures immunostained for extracellular matrix proteins were 
neither permeabilized nor acetone treated. Following blocking, SC- only and 
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nonmyelinating co-cultures were incubated with primary antibody for 1 h, while 
multilayered myelinating co-cultures were incubated overnight at 4°C. Secondary 
antibodies (goat-Alexa Fluor; Invitrogen) diluted 1:500 in block buffer were applied 
for 30 min. Cultures were postfixed in 4% paraformaldehyde for 5 min, stained with 
DAPI and, if applicable, Alexa 633-phalloidin, and were mounted in Fluorogel 
(Electron Microscopy Sciences). All cultures were analyzed with a Zeiss LSM710 
microscope and ZEN 2009 software. Image acquisition was optimized for each 
antibody in triple- or quadruple-stained cultures, and fluorescence was collected 
on separate channels. Images were identically acquired and processed for WT-
SC, SC-94, and SC-97 co-cultures, and are either single planes or maximum 
intensity projections as indicated in the figure legends. Focal contact/ adhesion (n 
= 14–32 whole cells per condition) and phalloidin mean intensity (sum pixel 
intensity divided by the number of pixels above background; n = 6–9 fields with 5–
12 cells per field) was obtained from three independent experiments and analyzed 
using one-way ANOVA and Tukey’s multiple comparison test with GraphPad Prism 
5. Krox-20 quantification was obtained from one experiment analyzed from Z 
stacks (7–11 slices at a 0.5 μm interval) acquired with a 40× objective. Stacks were 
analyzed with Volocity 5.5 software to acquire Krox-20 cytoplasmic (sum of pixel 
intensities above background in a Z series minus the sum of pixel intensities 
colocalized with DAPI-stained nuclei) and nuclear (sum of pixel intensities 
colocalized with DAPI-stained nuclei) expression. Five fields were analyzed for 
both sets of co-cultures. Data were analyzed with GraphPad Prism 5, Student’s t 
test. 
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NRG1 Stimulation-Cell Size Assay 
WT SCs were seeded onto PLL-coated (200 μg/ml) 12 mm round coverslips at 
5000 SCs per coverslip in D10M. Twenty-four hours later, cultures were starved 
for 16–18 h and then stimulated as described above for 30 min, fixed, and 
immunostained. For analysis, 50 individual SCs from three cultures per condition 
were imaged using a 20× objective. Images were analyzed using Volocity 5.5 
software to measure the two-dimensional size of individual cells lacking contacts 
with neighboring SCs. The area was averaged for both mock- and NRG1-
stimulated groups, and NRG-stimulated SC size was normalized to mock SCs. 
Four independent experiments were performed; p values (unpaired t test) were 
calculated using GraphPad Prism 5. SC-94 and SC-97 cells were seeded onto 
PLL- and PLL/laminin-coated 12 mm coverslips, grown for 24 h, starved for 16–18 
h, and then stimulated as above for 30 min and immunostained as described 
above. Phalloidin-Alexa 633 fluorescence was used to calculate cell area from 
isolated cells (n = 16–40 cells in each condition) in three independent experiments. 
Statistical analysis was performed using GraphPad Prism 5, one-way ANOVA, and 
Tukey’s multiple comparison test. 
 
Live Imaging, Cell Attachment, And Spreading Assay 
WT SCs and SC-97 and SC-94 cells were lifted by incubation in 0.05% trypsin, 
allowed to recover in D10M for 1 h at 37°C and 5% CO2, and seeded onto a 
MatTek 12-well plate coated with PLL (200 μg/ml) and laminin (25 μg/ml), with a 
10 mm glass insert at 5000 cells per insert. They were immediately placed on a 
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Zeiss wide-field microscope with full incubation control. Three to five fields were 
selected for each cell type, and images were collected with a Hamamatsu ORCA 
camera every 3 min for 3 h using a10× phase objective and Zeiss AxioVision 4.8.2 
software. Volocity 5.5 software was used to quantitate size (number of pixels) of 
individual cells. Four experiments were analyzed, and the mean number of pixels, 
SEM (n = 7 for each field), and p values (unpaired t test) were calculated using 
GraphPad Prism 5. 
 
Sudan Black Staining 
DRGN/SC co-cultures were prepared and analyzed as described by Chen et al. 
(2000). For analysis, coverslips were photographed with a 20× objective; nine of 
the most heavily myelinated fields were imaged on 4–16 coverslips of each WT-
SC, SC-97, and SC-94 co-culture. Myelin segments in each image were manually 
counted and summed for each coverslip in four independent experiments. The 
mean, SEM, and p values (unpaired t test) were calculated using GraphPad 
QuickCalcs Software. 
 
Electron Microscopy 
DRGN/SC co-cultures were prepared essentially as described by Fernandez-Valle 
et al. (1997). The glass coverslips were removed by dissolving them in hydrofluoric 
acid under a fume hood. Areas of co-cultures containing neurite fascicles were 
selected for analysis and were either cross-sectioned or sectioned en face. Three 
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independent co-cultures with WT SCs and SC-94 and SC-97 cells prepared with 
an MOI of 5 were analyzed by electron microscopy. 
 
Schwann Cell-Axon Alignment Assays 
DRGNs cultures were seeded with WTSCs and SC-97 and SC-94 cells labeled 
with CellTracker Green (CTG; Invitrogen). Labeling was performed according to 
the manufacturer’s protocol. For experiments using the LIMK inhibitor (BMS-5), 
labeled SCs were washed once in CB10 containing 1 μM BMS-5 before seeding 
in the same medium. After 24 h, the co-cultures were immunostained with 
neurofilament antibody and mounted as usual. For analysis, 10 randomly selected 
fields spanning the entire culture were imaged with a 20× objective from three 
cultures per condition. SC morphology was visually assessed for ~100 SCs in each 
type of co-culture as bipolar, tripolar, or multipolar by counting the number of 
processes emanating from the SC soma. The results shown for the noninhibitor 
study is a mean of three experiments, while the BMS-5 study is representative of 
two experiments. The mean, SEM, and p values (unpaired t test) were calculated 
using GraphPad Prism 5. For clarity, in Figure 10B, the expression of pS3-cofilin1 
is shown only for SCs (pS3-cofilin1 fluorescence that colocalized with 
neurofilament fluorescence was subtracted after acquisition using ZEN 2009 
software). pS3-Cofilin mean fluorescence intensity per cell was quantified using 
Volocity 5.5 software from 30 fields per condition. 
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Inhibitor Dose Response And Western Blot Analysis 
WT SCs were seeded on PLL-coated (200 μg/ml) six-well plates and incubated at 
37°C and 5% CO2 to 80–90% confluency in D10M. The medium was then replaced 
with fresh medium with and without serial dilutions of the LIMK inhibitor, BMS-5, 
and incubated for an additional 4 h. The control condition received only 0.1% of 
DMSO, the BMS-5 carrier. Western blot analysis was performed as described 
above and quantified using ImageJ software for three separate experiments. 
Quantitative analysis was done in Microsoft Excel software. 
 
Results 
NRG1 Promotes Dephosphorylation Of Cofilin, SSH1, And LIMK2 In SCs 
To determine whether NRG1 modulates actin dynamics by regulating cofilin1 
(hereafter referred to as cofilin) activity, we stimulated subconfluent starved normal 
SCs (WT SCs) with NRG1 for 5, 15, 30, and 60 min. WT SCs were also mock 
stimulated with the NRG1 carrier alone (mock). Equivalent volumes of lysate were 
analyzed by Western blot for phosphorylated and total levels of ErbB2 and cofilin 
(Fig. 1A). ErbB2 phosphorylation increased within 5 min of NRG1 stimulation and 
remained at three times the basal level for at least 1 h. pS3-Cofilin levels 
decreased by 50% within 5 min of NRG1 stimulation and remained at 30–50% of 
basal levels throughout the 1 h time course (Fig. 1B). To confirm that cofilin was 
dephosphorylated in response to ErbB2 activation, WT SCs were stimulated with 
NRG1 for 30 min in the presence and absence of an ErbB2 kinase inhibitor, AG825 
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(Osherov et al., 1993) (Fig. 1C, D). AG825 (10μM) inhibited both the 
phosphorylation of ErbB2 and the dephosphorylation of pS3-cofilin associated with 
NRG1 stimulation. NRG1 also promoted dephosphorylation of LIMK2 (T508) and 
SSH1 (S978) within 30 min of stimulation. Dephosphorylation of each protein was 
partially inhibited by AG825. The predominant isoform of LIMK detected in SCs 
was found to be LIMK2, and dephosphorylation of T508 reduced its kinase activity. 
SSH1 was expressed in SCs, and dephosphorylation of S978 activated its 
phosphatase activity. Thus, NRG1 promotes rapid dephosphorylation and 
activation of cofilin’s actin depolymerizing and severing activity by regulating the 
activities of both LIMK2 and SSH1. 
 
NRG1 Promotes SC Spreading And Recruitment of Cofilin To The Leading Edge 
We next analyzed the cellular response of WT SCs to 30 min of NRG1 stimulation. 
WT SCs were immunostained with antibodies to total cofilin, ErbB2, SSH1, LIMK2, 
and paxillin, and F-actin was visualized with phalloidin. We observed that NRG1 
induced formation of membrane protrusions and cell spreading. We used paxillin 
immunofluorescence to measure cell size and observed a 35 ± 6% (p < 0.01; n = 
4 experiments) increase in the size of NRG1-stimulated SCs compared to mock-
stimulated SCs. Cofilin was present at the leading edge of the plasma membrane 
and membrane protrusions in NRG1-stimulated but not in mock-stimulated SCs 
(Fig. 2). pS3-Cofilin antibody did not label the plasma membrane of NRG1-
stimulated SCs (data not shown), suggesting that plasma membrane-associated 
cofilin is active. ErbB2 and SSH1 were present at the leading edge of stimulated 
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SCs, whereas LIMK2 was not detected at the leading edge and remained in the 
cytosol and processes. These results are consistent with the conclusion that NRG1 
induces expansion of the SC plasma membrane by promoting cofilin recruitment, 
dephosphorylation, and activation at the leading edge. 
 
Cofilin Is Essential For SC Myelination 
To test the role of cofilin during myelination, we created cofilin-deficient SC lines 
using lentiviral delivery of cofilin shRNAi. Of the five target shRNAi tested, we 
found that shRNAi 94 reliably reduced cofilin protein levels by 80–90% of normal 
levels at an MOI of 5 (Fig. 3A–C). Cofilin shRNAi targets 95, 96, 97, and SCR 
promoted modest reductions in cofilin expression (10 to 30% decrease) at an MOI 
of 5. ShRNAi targets 94, 97, and SCR were used to generate passage-matched 
SC lines for analysis. Phalloidin staining and cofilin immunofluorescence revealed 
an increase in F-actin stress fibers and cell size in freshly plated, PLL-adherent, 
cofilin-deficient SC-94 cells compared to control SC-97 cells (Fig. 3D). In adhesion 
and spreading studies, we found that SC-94 cells adhered to laminin more quickly 
than SC-97 cells (compare sizes at 0.5 h) and elaborated more plasma membrane 
than SC-97 cells, becoming twice as large as SC-97 cells at 3.5 h of plating (Fig. 
3F, G). However, when SC-94 cells reached a high cell density, they aligned with 
each other as bipolar cells and were morphologically indistinguishable from SC-97 
(Fig. 3H) and WT SCs (data not shown). We also did not observe differences 
among SC-94, SC-97, and passage- matched WT SCs in proliferation rates and 
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cell-cycle progression as assessed with propidium iodide staining and flow 
cytometry (data not shown). 
 
To assess the role of cofilin in myelination, we seeded dissociated DRGN cultures 
with SC-94 and SC-97 and allowed them to develop for 10–14 d in myelination-
permissive medium. Sudan black stained myelin sheaths were quantified in four 
experiments (Fig. 4A; Table 1). We found that SC-94 cells were largely unable to 
produce myelin under conditions that supported myelination by SC-97 and WT 
SCs (data not shown). In areas of the co-culture with large axon fascicles, SC-94 
cells appeared to associate with axons but did not elongate along them. An easily 
observable change in morphology that accompanies SC alignment and 
differentiation into the myelinating phenotype is nuclear elongation. This change in 
nuclear morphology was infrequently observed in SC-94 cells maintained for 10– 
14 d in myelination-permissive medium (Fig. 4A). MAG was expressed at a low 
level by SC-94 cells, but it was not assembled into myelin (Fig. 4B). An occasional 
MBP-positive SC was observed in SC-94 co-cultures; however, the 
immunostaining pattern of the MBP- positive segments was abnormally thin and 
short (Fig. 4C). The occasional myelin segments could have been synthesized by 
SC-94 cells expressing relatively higher cofilin levels (Fig. 3E) or residual normal 
SCs from the purified DRGN cultures. In contrast, SC-97 and SC- SCR cells 
expressed MAG and MBP that were assembled into typical myelin sheaths. We 
also assessed whether SC-94 cells expressed Krox-20/Egr2, a myelin-specific 
transcription factor. Surprisingly, the Krox-20 expression level was higher in SC-
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94 than in SC-97 co-cultures; however, it largely localized to the cytosol rather than 
the nucleus (Fig. 4D,E). Last, the number of SCs in the co-cultures was counted 
to determine whether SC-94 cells failed to proliferate in contact with axons. Cell 
number was determined on the day after seeding onto neuron cultures as well as 
at the end of the 10 d myelinating period (Table 2). No differences in the number 
of SC-94 and SC-97 cells in the co-cultures were found. These results indicate that 
SC-94 cells proliferate in response to axonal NRG1 and express cytosolic Krox-20 
and MAG, but fail to assemble a myelin sheath. 
 
We conducted electron microscopic analysis of the co-cultures to assess the 
degree of morphological differentiation of SC-97 versus SC-94 (Fig. 5). In cross-
sections, both WT SCs and SC-97 cells (Fig. 5A,B, respectively) produced 
compact myelin. In contrast, SC-94 cells demonstrated limited and abnormal 
development (Fig. 5C). Large-diameter axons often remained unsegregated (a1, 
a2), and many SC-94 processes failed to adhere to axons (exemplified by 
processes 1 and 2). A single SC-94 cell engulfed multiple relatively large- diameter 
axons (a3-a5) while simultaneously extending processes around other axons 
(processes 1, 2, and 6). This morphology indicates a failure to establish a one-to-
one relationship with an axon. Additionally, this SC-94 cell produced 1.5 wraps 
around each of the larger-diameter axons (a3, a4) but the cytoplasmic processes 
were not polarized into typical mesaxons. A discontinuous basal lamina was also 
observed (Fig. 5C, inset, arrowheads). Whereas this amount of basal lamina 
deposition is not unusual for co-cultures at this stage of development, the observed 
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detached basal lamina is unusual. Ultrastructural analysis of en face sections of 
the co-cultures (Fig. 5D, E) confirmed the inability of SC-94 processes to form 
continuous close appositions with the axonal membrane. SC-97 cells formed close 
contacts with the axolemma (Fig. 5D, arrows); however, the processes of SC-94 
cells did not adhere consistently to the axon leaving stretches of the axolemma 
bare (E, arrows). The ultrastructural findings suggest that cofilin-deficient SCs fail 
to myelinate because they are unable to effectively regulate process extension, 
adhere to axons, and form typical basal lamina. 
 
Cofilin-Deficient SCs Have Abnormal Organization Of CTIV And Laminin 
Because basal laminin formation and actin polymerization are needed for 
expression of myelin-specific genes (Fernandez-Valle et al., 1994, 1997), and 
detached basal lamina was observed in the ultrastructural analysis, the ability of 
SC-94 cells to secrete and organize basal lamina components was assessed by 
immunostaining. WT SCs and SC-97 and SC-94 cells were co-cultured with 
sensory neurons and grown for 10 d in myelination-permissive medium. Co-
cultures were fixed but not permeabilized before immunostaining with antibodies 
to collagen type-IV (CTIV) and laminin. We found differences in the abundance 
and organization of CTIV and laminin in SC-94 co-cultures compared to SC-97 and 
WT-SC co-cultures (Fig. 6) (WT SCs not shown). CTIV was highly expressed but 
was organized in patches in SC-94 co-cultures, whereas it had a linear appearance 
in SC-97 and WT-SC co-cultures. Similarly, laminin was secreted and assembled 
into linear arrays in SC-97 and WT-SC co-cultures, but had an irregular distribution 
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in SC-94 co-cultures. These results demonstrate that cofilin- deficient SCs secrete 
but do not properly organize basal lamina components. 
 
Cofilin-Deficient SCs Do Not Align On Axons  
To better assess the interaction of SC-94 with axons, 10-d-old myelinating co-
cultures were immunostained for the SC-specific marker S100 and for 
neurofilament. We observed an unusual organization of SC-94 cells in the co-
cultures. Notably, cofilin-negative and S100- positive SC-94 cells adhered to the 
laminin substrate forming a monolayer of flat, wide bipolar cells. They did however, 
extend plasma membrane around neurofilament-positive neurites that contacted 
their surface but did not engage and align on the axons (Fig. 7). SC-97 cells 
expressing both cofilin and S100 adhered to axons and elongated along them as 
thin bipolar SCs, and minimally contacted the underlying laminin substrate. To 
further investigate the ability of SC-94 cells to interact with axons, we conducted 
axon-alignment assays using CTG-labeled SCs grown with DRGN cultures for 24 
h (Fig. 8A, B). We found that SC-97 cells, expressing 90% of normal cofilin levels, 
assumed a bipolar morphology within 24 h of seeding onto DRGN cultures. 
However, SC-94 cells, expressing only 20% of normal cofilin levels, were 
multipolar, a morphology incompatible with axon alignment. When SC-97 lines 
were prepared with 10 MOI of lentiviral transduction particles (as opposed to 5 
MOI), their cofilin level dropped to 60% of normal, and the frequency of multipolar 
SCs increased in the 24 h assay (data not shown). We also compared axon 
alignment of cofilin-deficient SCs after 48 h of seeding on DRGN cultures grown 
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on laminin versus collagen type 1 (Fig. 8C). SCs and their focal contacts and 
adhesions were visualized by immunostaining for vinculin. SC-94 cells failed to 
align along axon fascicles regardless of the substrate and the additional time. SC-
97 cells aligned as bipolar cells along axons grown on both substrates. We noted 
that SC-94 cells formed vinculin-positive focal contacts and adhesions on the 
underlying substrate that could interfere with axon alignment by possibly 
sequestering SC processes. Alternatively, enhanced SC-94 cell adhesion to the 
substrate could be secondary to their inability to stabilize processes on axons. This 
appears more likely, as SCs are seeded on top of well-established 12-d-old neuron 
cultures through which SC processes must navigate before reaching the 
underlying substrate. 
 
To assess whether SC-94 cells expressed normal levels of ErbB2 and integrin 
signaling proteins, Western blot analysis of isolated SC-94, SC-97, and WT SCs 
grown on laminin were conducted. The results revealed that SC-94 cells were 
deficient only in cofilin expression. These SCs expressed equivalent levels of the 
cofilin family member, ADF, as well as ErbB2, ERK1, N-cadherin, SSH1, α6 and 
β1 integrins, and the related signaling proteins, FAK and paxillin, which were both 
phosphorylated and thus active (Fig. 8D). These results suggest that SC-94 has 
intact ErbB2 and β1 integrin signaling pathways but is unable to modulate actin 
dynamics in response to receptor activity in the absence of cofilin. 
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Cofilin-Deficient SCs Do Not Increase In Cell Size In Response To NRG1 
We analyzed the cellular and biochemical responses of SC-94, SC-97, and WT 
SCs grown on PLL and on laminin to 30 min of NRG1 stimulation. The cells were 
immunostained for vinculin to label mature focal contacts and adhesions and with 
phalloidin. We assessed the number and length of focal contacts/adhesions, 
changes in F-actin levels, and cell size (Fig. 9A,B). SC-94 cells formed fewer but 
longer focal contacts/adhesions than SC-97 cells on both PLL and laminin. The 
vinculin-positive structures present in mock-stimulated SC-94 cells had insertions 
of F-actin stress fibers, which define them as focal adhesions (Katoh et al., 2011). 
In contrast, the vinculin-positive structures formed by SC-97 cells were largely 
devoid of stress fibers (Fig. 9A, insets). There was no significant change in the 
number or length of FAs between mock- and NRG1-stimulated conditions for either 
cell type. NRG1 stimulation generally resulted in a reduction in the amount of F-
actin compared to mock- stimulated cells that was statistically significant only in 
SC-97 cells grown on laminin (a 24% decrease). Whereas SC-97 cells increased 
in size by 50% following NRG1 stimulation on both PLL and laminin, SC-94 cells 
did not increase in size when grown on PLL, and decreased in size when grown 
on laminin (Fig. 9B). We also assessed the activity of the ErbB2 and β1 integrin 
signaling pathways in NRG1-stimulated WTSCs and SC-94 and SC-97 cells grown 
on PLL and laminin by Western blot analysis. An increase in ErbB2 
phosphorylation was detected following NRG1 stimulation for all cells grown on 
PLL compared to the mock condition. The increase in ErbB2 phosphorylation 
levels was modest for all cells when grown on laminin due to a higher level of basal 
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activation. SC-94 cells had comparable increases in phosphorylation of ERK, FAK, 
and paxillin to WTSCs and SC-97 cells on both substrates (Fig. 9C). These results 
indicate that SC-94 cells initiate ErbB2- and β1 integrin-dependent signaling 
cascades in response to NRG1, but are unable to extend plasma membrane and 
increase in size in the absence of cofilin. 
 
Phosphorylated Cofilin Is Necessary For SC Elongation On Axons 
We examined the localization and phosphorylation states of cofilin, LIMK, and 
SSH1 in normal SCs cultured with axons for 24 h. To distinguish between neuronal 
and SC- expressed proteins, SCs were prelabeled with CellTracker Green, and 
axons were identified by neurofilament expression. Within 24 h of seeding onto 
axons, high levels of pS3-cofilin, pErbB2, pLIMK, and pSSH1 were observed in 
bipolar SC processes contacting axons (Fig. 10A). In unaligned, multipolar SCs, 
pS3-cofilin was not detected in processes and was confined to the perinuclear 
cytosol (Fig. 10B). To determine whether cofilin phosphorylation was needed for 
SCs to align on axons as bipolar cells, the experiment was repeated in the 
presence of BMS-5, a highly selective, potent LIMK inhibitor (Ross- Macdonald et 
al., 2008) (Fig. 10C). Immunostaining confirmed a decrease in phosphorylation of 
cofilin S3 in BMS-5 treated versus carrier-treated SCs (Fig. 10D, E). Fewer bipolar 
SCs were observed in 24 h co-cultures grown in the presence of BMS-5 than in 
control co-cultures (Fig. 10F). These results suggest that phosphorylation of cofilin 
S3 is needed for SCs to adopt a stable bipolar morphology in association with 
axons. 
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Discussion 
The ability to rapidly expand plasma membrane is a unique biological function of 
myelinating SCs. Although myelin thickness has been genetically linked to the 
abundance of NRG1 on the axon surface (Michailov et al., 2004), the underlying 
pathways have not been elucidated. The present study sheds light on how NRG1 
regulates actin dynamics in isolated SCs to promote expansion of the plasma 
membrane and an increase in cell size. Our results demonstrate that NRG1 rapidly 
activates cofilin’s F-actin depolymerizing/severing activity in SCs and initiates 
membrane spreading. Moreover, we show that cofilin is required for the NRG1-
induced increase in cell size. Last, we show that cofilin-deficient SCs are unable 
toalign or myelinate sensory axons in vitro; thus. cofilin plays an essential role 
during myelination. 
 
NRG1 Stimulates A Cofilin-Dependent Increase In SC Size 
Cofilin directs the site of new membrane expansion by severing and 
depolymerizing F-actin to generate new barbed ends for localized actin 
polymerization (Oser and Condeelis, 2009). Our conclusions that these activities 
are activated by NRG1 and required for NRG1-directed increase in SC size are 
supported by the results presented in Figures 1-3 and 9. We show that within 30 
min of addition, NRG1 promotes a 35–50% increase in the size of WT SCs and 
SC-97 cells with a concomitant decrease in F-actin levels compared to the 
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respective mock-stimulated cells. These morphological changes are associated 
with NRG1/ErbB2- dependent dephosphorylation of cofilin at serine 3 that 
activates cofilin’s actin- depolymerizing/severing activity (Figs. 1, 9). The decrease 
in cofilin phosphorylation arises from NRG1-stimulated dephosphorylation and 
inhibition of LIMK and dephosphorylation and activation of SSH1 (Fig. 1) (Oser 
and Condeelis, 2009). Cofilin, but not pS3-cofilin (data not shown), is concentrated 
at the leading edge of protrusive membranes along with ErbB2 and SSH1 
phosphatase in WT SCs (Fig. 2). This suggests that recruitment to and activation 
of cofilin at the leading edge is responsible for initiating membrane spreading in 
response to NRG1. This conclusion is further supported by the failure of cofilin-
deficient SC-94 cells to increase in size following NRG1 stimulation (Fig. 9), 
although their innate ability to adhere and spread nondirectionally on laminin is 
enhanced compared to SC-97 cells (Fig. 3). This is consistent with a role for cofilin 
in localized membrane protrusions during chemotaxis of motile cells (Ghosh et al., 
2004). For example, cofilin is necessary for the response of carcinoma cells to 
EGF gradients (Mouneimne et al., 2006; Sidani et al., 2007). An increase in cell 
size and F-actin stress fibers subsequent to cofilin knockdown has been reported 
in other cell types (Hotulainen et al., 2005). 
 
SC-94 cells have similar levels of expression and activation of ErbB2, N-cadherin, 
α6 and β1 integrins and downstream effectors, ERK1/2, FAK, and paxillin as SC-
97 and WT SCs (Fig. 8). Thus, pathways needed to respond to NRG1 appear intact 
in cofilin-deficient SCs. The related cofilin molecule ADF is expressed in SCs, and 
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its expression level was unaltered following cofilin depletion. Because ADF did not 
functionally compensate for cofilin in SC-94 cells, it appears to have a distinct role 
in SCs. Overall, these studies demonstrate that cofilin is dephosphorylated in 
response to NRG1 stimulation and recruited to the leading edge of isolated SCs, 
where it participates in severing and/or depolymerizing F-actin to promote 
directional cell spreading. 
 
Cofilin Is Essential For Myelination 
We hypothesized that cofilin activity would be necessary for polarized expansion 
of the SC membrane during myelination. We sought to test this hypothesis by 
coculturing cofilin- deficient SCs with sensory neurons and assessing their ability 
to form a myelin sheath. Surprisingly, we found that cofilin-deficient SCs are unable 
to even effectively engage axons and stably appose them. During the initial 24–48 
h of interaction, SC-94 cells fail to extend bipolar processes along axons (Fig. 8). 
Over the following week, SC-94 cells adhere to the laminin substrate as flattened 
bipolar cells and develop focal contacts/adhesions. Isolated SC-94 cells form 
atypically long focal adhesions on both PLL and laminin compared to the focal 
contacts/adhesions formed by SC-97 cells (Fig. 9). It has been shown that focal 
adhesion turnover requires cofilin and F-actin depolymerization (Gupton et al., 
2007; Marshall et al., 2009; Maruthamuthu et al., 2010). The aberrant adhesion 
and spreading of SC-94 cells on the substrate could be a consequence of their 
inability to stably engage axons in the absence of cofilin and is discussed below. 
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While our standard myelination assay is conducted over 10–14 d, SC-94/DRGN 
co-cultures grown for 4 weeks in myelin-permissive medium did not further 
differentiate (data not shown), indicating that SC-94 cells were not simply delayed 
in differentiation. We also did not find differences in the number of DAPI- and Ki67-
positive SC-94 cells in the DRGN cultures compared to controls (Table 2) (data 
not shown), indicating that cofilin-deficient SCs proliferate in response to axonal 
NRG1. Our analysis of the ErbB2 and β1 integrin pathways in isolated SC-94 cells 
and their ability to proliferate in response to soluble and axonal-NRG1 suggest that 
cofilin-deficient SCs activate pathways necessary for differentiation but cannot 
execute directed morphological changes in the absence of cofilin. This is 
supported by the low-level expression of MAG and cytosolic Krox-20 in SC-94 
compared with controls. Translocation of Krox-20 into the nucleus is regulated by 
its interaction with 14-3-3 protein that maintains it in the cytoplasm (Dillon et al., 
2007). Because cofilin directly binds 14-3-3 (Gohla and Bokoch 2002), loss of 
expression of this abundant protein in SCs could increase levels of free 14-3-3, 
thereby perturbing the balance of nuclear/cytosolic Krox-20 and contributing to the 
inability of SC-94 cells to myelinate. Contact between the SC and axon is needed 
for development of basal lamina. The deposition of basal lamina by cofilin-deficient 
SCs resembled that reported in studies in which direct contact between SCs and 
axons was prevented (Clark and Bunge, 1989). This early study revealed that SCs 
assemble normal-appearing basal lamina only when they ensheathe axons. Thus, 
the abnormal distribution of laminin and basal lamina in SC-94/DRGN co-cultures 
could arise from their inability to stably engage axons as elongated bipolar cells. 
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Abnormal laminin deposition and consequent aberrant motility have also been 
reported in keratinocytes and arose from deregulation of β4 integrin signaling to 
Rac1 and cofilin1 (Sehgal et al., 2006). 
 
Phosphorylated Cofilin Plays A Role In SC Engagement Of Axons 
SC-94 cells retain the ability to extend plasma membrane around axons but do so 
in an “unregulated” manner, as shown in Figure 5 and 7. Cofilin-deficient SCs 
engulf and wrap multiple axons at once, intermittently contact others, and fail to 
segregate larger-diameter axons. The inability to closely appose and adhere to 
axons could be due to an inability to stabilize their cytoskeleton in response to 
ErbB2 activation in the absence of cofilin. This possibility is supported by the 
distribution of pS3-cofilin in normal SC/DRGN co-cultures (Fig. 10). Bipolar SC 
processes contained higher levels of phosphorylated cofilin S3, LIMK, and SSH1 
than multipolar processes of axon-associated SCs. Moreover, inhibition of LIMK 
activity reduced pS3-cofilin levels in SCs, and concomitantly their ability to align 
bipolar processes on axons. This suggests that cofilin S3 phosphorylation plays a 
role during early differentiation and is needed to stabilize SC–axon contacts during 
axon engagement. Previously, phosphorylated ErbB2 and the Cdc42/Rac guanine 
exchange factor Dock7 were shown to be present at the leading edge of 
membrane protrusions in migrating SCs (Yamauchi et al., 2008). Thus, NRG1 
could stimulate Cdc42/Rac-PAK1-dependent phosphorylation and activation of 
LIMK, leading to cofilin S3 phosphorylation during the initial alignment of SC on 
axons. Alternatively, cofilin could be phosphorylated in response to β1 integrin 
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activation of Cdc42/Rac/Pak or Rho/ROCK, both of which phosphorylate LIMK. 
ROCK has been shown to play a role in SC myelination (Melendez-Vasquez et al., 
2004). 
 
Previous studies suggested that pS3-cofilin plays an important role in phospholipid 
signaling (Bernstein and Bamburg, 2010) by binding and sequestering PIP2 on the 
membrane (van Rheenen et al., 2007). A role for PIP3 in myelination has been 
demonstrated previously (Goebbels et al., 2010). A concomitant decrease in PIP2 
levels observed in PTEN (phosphate and tensin homolog)-null sciatic nerves could 
lead to rampant cofilin activation and contribute to the observed hypermyelination. 
Additionally, pS3-cofilin directly stimulates phospholipase D1 in response to 
receptor activation (Han et al., 2007). This enzyme is regulated by Rho GTPases, 
protein kinase C, and PIP2 (Rudge and Wakelam, 2009). Phosphatidic acid 
regulates integrin-dependent adhesion and cytoskeletal remodeling, binds mTOR 
(mammalian target of rapamycin) and S6 kinase, and enriches the Rac guanine 
exchange factor DOCK2 at the leading edge of neutrophils (Gomez-Cambronero, 
2010). Hence, the phenotype observed in cofilin-deficient SCs potentially reflects 
deregulation of phospholipid signaling as well as actin dynamics. 
 
Cofilin is an end target for both NRG1 and laminin signaling. Our results support 
the conclusion that the spatiotemporal balance of phosphorylated and 
dephosphorylated cofilin S3 regulates SC function during myelination. During axon 
engagement, an increase in cofilin S3 phosphorylation would stabilize F-actin and 
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decrease process motility, allowing adhesive SC–axon interactions to develop. 
During active myelination, dephosphorylation of cofilin S3 triggers directed 
expansion of the plasma membrane in response to NRG1. A working model 
summarizing our results is presented in Figure 11. Future studies will test the 
hypothesis that localized cofilin dephosphorylation along the inner mesaxon 
contributes to its motility during active myelination. 
 
Figures And Tables 
 
Figure 5. NRG1 promotes dephosphorylation of cofilin, LIMK2, and SSH1 in SCs.  
(A) Subconfluent normal (WT-SC) cultures grown on PLL-coated wells were starved of 
serum and mitogens overnight by incubation in DMEM containing 0.5% FBS (D0.5). They 
were stimulated with D0.5 plus NRG1 (NRG) or with fresh D0.5 plus NRG1 carrier (Mock) 
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for the indicated times and were extracted in SDS sample buffer. Equal volumes were 
used in Western blot analysis with the indicated antibodies recognizing total and 
phosphorylated epitopes (pS3- cofilin and pY1248-ErbB2) and GAPDH. S100 was used 
as an SC marker. (B) Quantification of the global changes in phosphorylation following 
NRG1 stimulation is shown. The graph depicts the mean and SEM of the ratio of 
normalized phosphorylated/total protein in four independent experiments for each time 
point. (C) Subconfluent WT SCs grown on PLL were starved and stimulated as above for 
30 min in the presence and absence of (20μM) AG825, an ErbB2 inhibitor. Western blots 
were performed with total and phospho-antibodies (pS978-SSH1 and pT505/508-
LIMK1/2). (D) The mean and SEM of the normalized ratio of phosphorylated to total protein 
after normalization of each to the Mock condition is shown for four independent 
experiments. NRG1 promotes ErbB2 phosphorylation and cofilin dephosphorylation with 
similar time courses. AG825 inhibits ErbB2 phosphorylation and decreases 
dephosphorylation of cofilin, LIMK, and SSH1. *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 
0.0001. 
 
 
Figure 6. Cofilin is recruited to the leading edge in response to NRG1. 
 Subconfluent SC cultures grown on PLL-coated glass coverslips were starved and 
stimulated as described in Figure 1 for 30 min. They were immunostained with antibodies 
to total cofilin, ErbB2, SSH1, and LIMK2 (all shown in green) and with phalloidin (red). In 
mock-stimulated cells, only ErbB2 was present at the plasma membrane. In NRG1-
stimulated cells, cofilin, ErbB2, and SSH1 were present in the cytosol as well as at the 
leading edge of plasma membrane protrusions. LIMK2 was localized predominantly in the 
cytosol and in processes in NRG-stimulated cells, and was not observed at the leading 
edge. All images are maximum intensity projections of six-slice Z stacks using a 0.5 μ 
minterval. Arrowheads indicate the leading edge of the plasma membrane. Scale bars: 20 
μm. 
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Figure 7. Generation of cofilin-deficient Schwann cells. Lentiviral delivery of cofilin shRNAi 
was used to create cofilin-deficient SCs.  
(A) Schematic alignment of the shRNAi targets 93–97 on rat (Rattus norvegicus) cofilin-1 
(NM017147) is shown. B, Western blots reveal the protein levels of cofilin and GAPDH in 
stable lentiviral-transduced (5 MOI) WTSCs expressing SCR and TurboGFP and shRNAi 
targets 93–97. (C) Quantification of cofilin levels (B) normalized to GAPDH and expressed 
relative to WTSCs. (D) Immunofluorescence staining for cofilin and F-actin using phalloidin 
in WTSCs and stable SC-97 and SC-94 lines verifies that SC-94 cells express low levels 
of cofilin, while WT SCs and SC-97 cells express cofilin. Phalloidin staining shows an 
increase in F-actin stress fibers and cell size in SC-94 compared to controls. (E) 
Quantification of cofilin levels (D) of 20–30 individual WTSCs and SC-97 and SC-94 cells 
show a distribution of cofilin expression levels. (F) SC-94 and SC-97 cells were seeded 
onto laminin-coated glass coverslips and imaged in real time for 3.0 h beginning 0.5 h 
after seeding in five separate experiments. Frames captured at 0.5 and 3.5 h are shown 
and reveal that SC-94 cells attach to laminin more quickly and spread more plasma 
membrane than control SC-97 cells. (G) Quantification of cell size is shown in F. *p < 0.05; 
**p < 0.002. (H) Images of SC-94 and SC-97 grown on PLL-coated glass coverslips reveal 
that cofilin deficiency in SC-94 cells does not interfere with acquisition of a bipolar 
morphology at high cell density. Scale bars: 20 μm. 
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Figure 8. Cofilin is required for SC myelination.  
(A) In four separate experiments, DRGN/SC co-cultures were assessed for myelination by 
Sudan black staining after 10–14 d of growth in myelin-permissive medium. SC-97 (top) 
robustly myelinated sensory axons, whereas SC-94 (bottom) myelinated very infrequently. 
At higher magnification (right), SC-94 cell shave rounded nuclei rather than oval nuclei as 
is typical for myelinating SCs. The oval nuclear shape of myelinating SC-97 is somewhat 
obscured but is visible in the cells indicated with arrows. Co-cultures grown for 10 d in 
myelination-permissive medium were also immunostained for MBP, MAG, paxillin, 
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neurofilament (NF), and Krox-20 expression. (B) SC-97 cell sproduced MBP-positive 
myelin segments with normal appearance; however, some SC-94 cells expressing higher 
cofilin levels produced occasional MBP-segments that were abnormally thin and short. (C) 
A subpopulation of SC-SCR (expressing scrambled shRNAi) cells expressed MAG and 
incorporated it into normal-appearing myelin segments, whereas all SC-94 cells 
expressed low levels of MAG that was not assembled into myelin. (D) Single-plane images 
of DRGN/SC co-cultures are shown. Krox-20 was expressed in the nuclei of SC-97 cells 
with only limited expression in the perinuclear region (inset). In contrast, Krox-20 
immunoreactivity in SC-94 cells was largely cytoplasmic (see arrowheads), even 
extending into processes with low levels present in the nucleus (inset). DAPI-stained 
nuclei are shown in blue. (E) Quantification of total Krox-20 intensity and ratio of 
nuclear/total intensity normalized to the number of nuclei (mean of 5 Z stacks with 7–11 
slices using a 0.5 μm interval). SC-94 cells expressed more Krox-20 than SC-97 cells, but 
it is predominantly localized in the cytosol. ***p < 0.001, ****p < 0.0001. Scalebars: A, low 
magnification, 50 μm; high magnification, 20 μm; B, C, D, 20 μm; inset in D, 5 μm. 
 
 
Table 1. Quantification Of Sudan Black-Stained Myelin Segments 
 
Experiment Cell Type N* Mean  SEM % Decrease p value 
1 SC-97 4 184  33 85 0.0005 
 SC-94 6 27  7   
2 SC-97 6 12  4.6 90 0.039 
 SC-94 6 1  0.6   
3 SC-97 16 1095  96 98 0.0001 
 SC-94 14 15  5   
*Number of DRGN/SC co-cultures examined 
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Figure 9. Cofilin is necessary for normal SC–axon interactions.  
(A–E) Ultrastructural analyses were conducted on cross (A–C) and en face sections (D, 
E) of DRGN/SC co-cultures grown for 10 d in myelin-permissive medium. Where as 
WTSCs (A) and SC-97 cells (B) produced normal-appearing myelin within this time frame, 
SC-94 cells (C) did not. Large-diameter axons were not effectively segregated by SC-94 
(axons a1, a2). SC-94 did not form a one-to- one relationship with axons, but rather 
elaborated multiple processes around both large- and small-diameter axons. Numbers 
indicate separate processes from a single SC-94 cell attempting to wrap two larger axons 
and multiple small ones (a3–a5). Arrowheads and the inset show discontinuous basal 
lamina (C). En face sections show that SC-97 processes formed tight appositions with 
axons (D, arrows), where as SC-94 processes did not adhere well to axons (E, arrows). 
Scale bars: 1 μm. 
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Table 2. Number Of DAPI-Stained SCs in DRGN/SC Co-cultures 
 
 
Figure 10. Cofilin-deficient SCs assemble an atypical extracellular matrix.  
We assessed the ability of SC-94 to secrete and assemble basal lamina components by 
immunostaining DRGN/SC co-cultures grown for 10 d in myelination-permissive medium 
with antibodies to CTIV and LAM. Co-cultures were not permeabilized before 
immunostaining. CTIV was expressed by SC-97 and was assembled into linear arrays, 
whereas CTIV was expressed by SC-94 at high levels but was organized in patches 
throughout the co-culture. Laminin was secreted and assembled into linear arrays in SC-
97 co-cultures, whereas it had an irregular distribution in SC-94 co-cultures. Images are 
maximum intensity projections of 10 Z series collected at 0.4 μm intervals. Scale bars: 20 
μm. 
Experiment Cell Type N* Mean  SEM p value 
1, M10d SC-97 10 178  10 0.1029 
 SC-94 10 153  10  
2, M10d SC-97 20 75  2 0.1258 
 SC-94 20 100  10  
3, CB1d SC-97 24 122  16 0.4125 
 SC-94 24 108  7  
*Total number of fields; M10d, co-cultures grown for 10 d in myelination feed; CB1d, co-
cultures seeded with SCs for 1 d. 
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Figure 11. Cofilin-deficient SCs do not engage axons.  
We used S100 and neurofilament immunostaining to examine the interaction between 
cofilin-deficient SCs and axons in DRGN/SC co-cultures grown for 10 d in myelination-
permissive medium. We also tested for cofilin expression to verify that cofilin levels 
remained low in SC-94. Images are single planes. A, Cofilin was expressed by SC-97 and 
localized throughout the SC and its bipolar processes. B, Cofilin levels were reduced in 
SC-94 co-cultures. C, D, Similar areas of SC-97 and SC-94 co-cultures are shown. S100-
positive SC-97 (green) aligned on axons (red), whereas SC-94 adhered to the laminin 
substrate and spread into large bipolar cells. However, SC-94 extended plasma 
membrane around axons that contacted their surface. E, F, Neurofilament and DAPI 
staining of the fields shown in B are presented. Scale bars: 20 μm. 
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Figure 12. Cofilin is required for alignment of SCs on axons.  
(A) Representative single-plane images of the morphology of CTG-labeled SC-97 (10% 
cofilin knockdown) and SC-94 cells (80% cofilin knockdown) is shown 24 h after seeding 
onto neurons (immunostained with neurofilament; red). SC-94 cells did not assume a 
bipolar morphology and did not align with the axons. (B) Quantification of cell morphology 
of SC-94 and SC-97 cells is shown. Eighty percent of SC-94 cells exhibited a multipolar 
morphology, while <20% of WT SCs and SC-97 cells were multipolar. The cofilin levels of 
SC-94 and SC-97 cells were measured by Western blot analysis. ***p < 0.001. (C) SC-97 
and SC-94 lines were co-cultured with DRGNs grown on two different substrates, LAM 
and collagen (COL). Forty-eight hours after seeding onto neurons, co-cultures were fixed, 
and neurons were immunostained with neurofilament (red) and SCs with vinculin (green) 
to visualize SCs and focal adhesions. Images are single planes of representative areas. 
SC-94 cells were unable to assume a bipolar morphology and align along neurons grown 
on either substrate. (D) Total protein extracts of WT SCs and SC-97 and SC-94 cells 
grown normally for 48 h on LAM were blotted for basal levels of adhesion molecules 
(integrins, N-cadherin) and other downstream signaling molecules. Cofilin deficiency did 
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not correlate with an aberrant expression of other proteins, and viral transduction had no 
effect on expression levels of the tested proteins. Scale bars: 20 μm. 
 
 
Figure 13. Cofilin-deficient SCs do not increase in size in response to NRG1.  
Subconfluent SC lines grown on PLL and PLL/LAM were starved and stimulated with NRG 
as described in Figure 1. A, SC lines grown on LAM were immunostained with antibodies 
to vinculin (green) and stained with phalloidin (red) to visualize focal contact/adhesions 
and F-actin, respectively. Scale bars: 20 μm; inset, 5 μm. B, Quantification of the number 
and length of FAs per cell, mean pixel intensity of phalloidin, and cell area are shown. SC-
94 cells had fewer but longer FAs than SC-97 cells. SC-94 cells did not respond to NRG1 
stimulation on PLL, or decreased in cell size after stimulation LAM, while SC-97 cells 
showed a significant increase on both substrates. Three independent experiments were 
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analyzed. *p < 0.05; **p < 0.01; ***p < 0.001. C, Western blot analysis of 30 min NRG-
stimulation assays of subconfluent WT SCs and SC-94 and SC-97 cells grown on PLL or 
LAM culture dishes are shown. No significant differences in protein phosphorylation were 
observed for SC-94 cells with respect to the controls. 
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Figure 14. Cofilin S3 phosphorylation is necessary for SC alignment on axons. DRGN 
cultures were seeded with CTG-labeled WT SCs.  
Co-cultures were fixed 24 h later and immunostained with antibodies to phosphorylated 
ErbB2, cofilin, LIMK, and SSH1 (all shown in red) and neurofilament (NF; white) to 
visualize axons. All Images are single planes optimized for each antibody. A, 
Phosphorylated forms of cofilin, LIMK, and SSH1 are present in the bipolar processes of 
SCs aligned along axons (arrows indicate protein in axon-aligned SCs). B, A single image 
of co-cultures reveals pS3-cofilin is present in processes of bipolar, aligned WTSCs, but 
not in those of multipolar SCs (insets i, ii). Only pS3-cofilin expression in the SC is shown. 
C, BMS-5, a LIMK inhibitor (LIMKi), inhibits cofilin phosphorylation in a dose-dependent 
manner. WT SCs were incubated for 4 h with serial dilutions of the inhibitor, and total cell 
extracts were assessed for pS3-cofilin levels and GAPDH as a loading control. The 
expression level of pS3-cofilin relative to GAPDH expression is plotted as a function of 
BMS-5 concentration. D, Representative images of a 24 h axon alignment assay 
conducted with SCs grown in the absence (DMSO control) and presence of 1 μM BMS-5 
(LIMKi) and pS3-cofilin (red) is shown. The mean pixel intensity (MI) for pS3- cofilin in the 
image shown is provided. E, Quantification of pS3-cofilin immunofluorescence for the 
experiment shows a statistically significant reduction in pS3- cofilin in LIMK inhibitor-
treated cultures compared to controls (mean ± SEM; 30 fields per condition). F, 
Quantification of SC morphology reveals fewer bipolar, aligned WT SCs in co-cultures 
grown in the presence of LIMKi than in controls. A graph of a representative experiment 
of three is shown with mean ± SEM. *p < 0.05; **p < 0.01. Scale bars: 20 μm. 
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Figure 15. Working model for cofilin function during Schwann cell myelination. 
We propose that the spatiotemporal balance of cofilin serine 3 phosphorylation and 
dephosphorylation regulates actin polymerization dynamics downstream of ErbB2/B3 and 
β1 integrin signaling in Schwann cells contacting axons. Schwann cell alignment on axons 
is facilitated by shifting the balance toward cofilin serine 3 phosphorylation that favors F-
actin stabilization. In the absence of significant basal lamina deposition, α6β1 integrin and 
ErbB2/B3 receptors exist as a complex throughout the Schwann cell plasma membrane. 
Clustered β1 integrins activate Cdc42/Rac-dependent-Pak kinase (Thaxton et al., 2008) 
that increases LIMK- dependent phosphorylation of cofilin serine 3. As basal lamina 
develops, the receptors become polarized to opposing plasma membranes. Basal lamina 
clusters α6β1 integrin to promote cofilin serine 3 phosphorylation and stabilization of F-
actin along the abaxonal plasma membrane. In contrast, NRG1 activation of ErbB2/B3 
along the adaxonal plasma membrane inhibits LIMK and promotes SSH1 activity, which 
shifts the balance toward cofilin serine 3 dephosphorylation. Cycles of cofilin 
phosphorylation and dephosphorylation at the leading edge of the inner mesaxon allow 
expansion of the Schwann cell plasma membrane around the axon during active 
myelination. 
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CHAPTER THREE: MERLIN MODULATES NEUREGULIN-COFILIN 
SIGNALING DURING SCHWANN CELL MYELINATION TO 
ESTABLISH MYELIN SEGMENT LENGTH 
Introduction 
Schwann cells form the multi-lamellar myelin sheath surrounding axons in the 
peripheral nervous system (PNS). During nerve development, Schwann cells 
(SCs) migrate along axons and sort them according to diameter by extending and 
retracting lamellipodia-like protrusions either in parallel or perpendicular (radial) to 
axons (Jessen and Mirsky, 2005; Pereira et al., 2011). Once SCs establish a 1:1 
relationship with the axonal domain destined for myelination, and basal lamina is 
present, they begin to synthesize new membrane and myelin proteins while 
simultaneously driving their expanding adaxonal membrane (that which touches 
the axolemma) repeatedly around the axon to generate the myelin sheath. 
Underlying these processes is the spatial-temporal regulation of actin filament 
assembly and disassembly by actin polymerizing/depolymerizing proteins. Control 
of actin dynamics needed for SC myelination remains poorly understood 
(Fernandez-Valle et al., 1997). 
 
Recently we showed that cofilin, a member of the small (18kDa) actin 
depolymerizing factor family, is essential for SC myelination (Sparrow et al., 2012). 
Cofilin enables effective engagement of SCs with axons, and its activity is 
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regulated by a key molecule stimulating peripheral myelination, axonal-bound 
neuregulin1-type III, that activates the receptor tyrosine kinases (RTKs) 
ErbB2/ErbB3 in SCs (Michailov et al., 2004; Taveggia et al., 2005). Cofilin severs 
F-actin to achieve two functions. The first is to replenish the pool of G-actin 
monomers available for incorporation into growing actin filaments, and the second 
is to create barbed ends for nucleation of new F-actin branches (Bravo-Cordero et 
al., 2013). Its activity is regulated in several ways, but the best characterized is by 
phosphorylation/dephosphorylation on serine 3. LIM domain kinase (LIMK) 
phosphorylates S3-cofiin and decreases its actin severing activity by inhibiting 
cofilin’s ability to associate with F-actin (Moriyama et al., 1996). LIMK is 
phosphorylated and activated by Rac/p21-activated kinase (PAK) (Edwards et al., 
1999). LIMK can also be phosphorylated and activated by Rho-associated kinases 
(ROCK) and the myotonic dystrophy kinase-related Cdc42-binding kinase (MRCK) 
(Manetti 2012). Slingshot (SSH) is the major phosphatase that dephosphorylates 
S3-cofilin, leading to activation of cofilin. SSH activity is regulated by 
phosphorylation on S978 by PAK, which inhibits its ability to dephosphorylate and 
activate cofilin (Huang, et al. 2006). 
 
Mutations in the Nf2 gene result in the disorder Neurofibromatosis Type II (NF2), 
which predisposes individuals to formation of schwannomas on cranial and 
peripheral nerves (Petrilli and Fernandez-Valle 2016). The tumor suppressor 
merlin (also known as schwannomin), encoded by the Nf2 gene, regulates both 
Rac (Morrison et al., 2007) and PAK (Kissil et al., 2003). Merlin is a member of the 
 55 
FERM domain containing, 4.1 superfamily of proteins that link the actin 
cytoskeleton to membrane receptors, and regulates both growth and proliferation 
signaling pathways as well as those regulating actin dynamics. Cultured human 
schwannoma cells exhibit excessive Rac-associated membrane ruffling, and 
increased levels of both F-actin and focal adhesions (Pelton et al., 1998; Zhou et 
al., 2011). Merlin’s activity is regulated by phosphorylation on S518 by protein 
kinase A (PKA) (Alfthan et al., 2004) and PAK (Kissil et al., 2002), which decreases 
its tumor suppressor activity. We previously demonstrated that in SCs specifically, 
merlin is phosphorylated on S518 by protein kinase A (PKA) downstream of 
ErbB2/ErbB3 activation, and by p21-activated kinase (PAK) downstream of B1 
integrin activation (Thaxton et al., 2008). 
 
A role for merlin in regulation of SC myelination has been suggested by several in 
vivo studies. Mice with a SC-specific inactivation of merlin form schwannomas, and 
exhibit a mild dysmyelinating phenotype, including SC hyperplasia, decreased 
internodal length, and paranodal defects (Giovannini et al., 2000; Denisenko et al., 
2008). Conversely, we showed in an in vitro study that myelin internode length was 
significantly increased when wild type merlin was overexpressed at the time of 
myelination induction in DRG neuron/SC co-cultures, further suggesting that 
merlin plays a role in controlling the ultimate length of the myelin sheath (Thaxton 
et al., 2011). 
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Here we report that merlin indirectly suppresses LIMK activity downstream of 
neuregulin signaling allowing for activation of cofilin, and ultimately influencing 
myelin internodal length. Schwann cells with loss of merlin function migrate on and 
align with axons as well as differentiate and express myelin basic protein when 
grown in myelin-permissive conditions. However, merlin-deficient SCs form short 
myelin segments and do not activate cofilin in response to neuregulin. These 
studies suggest a role for merlin as an upstream regulator of cofilin activity during 
peripheral myelination.  
 
Materials And Methods 
Materials And Antibodies 
Mission shRNA lentiviral transduction particles targeting human merlin, control 
non-target (scrambled) shRNA transduction particles, and puromycin were 
purchased from Sigma-Aldrich (St. Louis, MO). 2.5S nerve growth factor (NGF) 
was purchased from Harlan (Indianapolis, IN) and recombinant human 
neuregulin1-type III-SMDF (NRG) was purchased from R&D Systems 
(Minneapolis, MN). Antibodies for the following proteins were purchased from 
these sources:  GAP43, merlin, neurofilament-heavy chain, PLP, Sox10 from 
Abcam (Cambridge, MA), S100 from Dako (Denmark), Cofilin-1 from Novus 
(Littleton, CO), pS3-cofilin-1, LIMK1, pT505/508-LIMK1/2, β-Actin, YAP from Cell 
Signaling (Davers, MA), MBP from Covance (Princeton, NJ), ErbB2, pY1248-
ErbB2 from Santa Cruz Biotechnology (Santa Cruz, CA), Paxillin from BD 
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Biosciences, Rac-GTP from New East Biosciences, DAPI, Alexa Fluor conjugated 
secondary antibodies, Alexa Fluor 633-phalloidin from Life Technologies (Grand 
Island, NY), O4 and P0 were kind gifts of Dr. Paula Monje (University of Miami). . 
All cell culture reagents were purchased from Life Technologies unless otherwise 
stated. The LIMK inhibitor BMS-5 (C17H14Cl2F2N4OS) was purchased from 
Synkinase. 
Preparation And Culture Of Rat Primary SCs 
Primary rat SCs were isolated from sciatic nerves of 8-12 two-day-old Sprague 
Dawley (Charles River, North Wilmington, MA) pups and prepared using the 
Brockes method with modifications as described (Brockes et al., 1979). Nerves 
were cleaned of connective tissue and blood vessels, and then digested by 
submersion in PBS with 1mg/ml collagenase for 20min, followed by 0.25% trypsin 
for 20min. Enzymes were inactivated twice with D10 (DMEM, 1x Pen/Strep, with 
10% heat inactivated fetal bovine serum (HIFBS, Atlanta Biological, Atlanta, GA)) 
and centrifugation at 1500rpm for 5min at 4ºC. To obtain a single cell suspension, 
nerves were disassociated manually by triturating with small bore Pasteur pipettes. 
The single cell suspension was then plated into an uncoated, polystyrene Corning 
60mm in D10 and cultured at 37ºC and 7% CO2. To purify the culture, 18-24hrs 
later culture medium was changed to D10+1mM Ara-C for two days, and then 
again for another three days. On the seventh day post dissection, cultures were 
further by Thy1.1 incubation followed by guinea pig complement treatment. The 
remaining cells were then plated into a 200µg/ml Poly-L-Lysine (PLL; Sigma, St 
Louis, MO) coated 100mm dish in D10M medium (D10 with 2µM forskolin (Sigma, 
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St Louis, MO) and 20µg/ml pituitary extract (BTI, Stockbridge, MA)). Purified rat 
Schwann cells were routinely cultured on PLL-coated dishes in D10M at 37ºC and 
7% CO2, fed twice a week, split 1:3 when they reached 95-100% confluency, and 
used until passage 20. 
 
Generation Of Merlin Deficient Schwann Cell Lines 
shRNA target-45 (Sigma Mission) against human NF2/merlin mRNA has a 100% 
alignment to rat merlin mRNA and yielded a 95% reduction in merlin levels. Merlin-
deficient SCs were generated in a similar manner to that of the Coflin-deficient SCs 
as previously described (Sparrow et al., 2012). Briefly, freshly purified rat SCs were 
plated onto PLL-coated 6-well dishes and were cultured in D10M at 37ºC and 7% 
CO2. When the cultures reached 70-80% confluency, lentiviral transduction 
particles were added at a multiplicity of infection (MOI) of 5 in D10M plus 8µg/ml 
hexadimethrine bromide (Sigma, St Louis, MO). After 18-20 hours, the infection 
medium was replaced with D10M for 24 hours, at which time culture medium was 
changed to D10M containing 1µg/ml Puromycin (Sigma, St. Louis, MO). SCs were 
maintained in D10M plus puromycin and were passaged to expand the population. 
During expansion, the merlin expression level was assessed by extracting SCs 
directly in SDS-PAGE sample buffer and conducting western blot analysis. SCs 
expressing scrambled (SCR) shRNA, along with untransduced, primary SCs, were 
used to control for the effects of lentiviral transduction, puromycin selection and 
passage number. Two independent merlin KD-SC lines were created and both had 
a similar reduction in merlin levels. 
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Preparation Of Rat Disassociated DRG Neuron/SC Co-Cultures 
Dorsal root ganglia (DRG) were harvested from Sprague Dawley rat embryos at 
15 - 17 days of gestation (E15-E17) and were dissociated in 2mL of 0.25% trypsin, 
in a 35mm petri, for 20min in the incubator. Enzymes were inactivated and 
removed with CB10 (MEM with 10% HIFBS) was used. Dissociated DRG neurons 
(DRGN) were plated at 0.2 ganglion per well in PLL (200µg/ml) and laminin 
(50µg/ml) coated 96-well plates with black sides in a total volume of 100µl CB5 
medium (MEM, 0.4% glucose, and 50ng/ml 2.5S NGF, 5% HIFBS). They were 
placed in EF2 medium (CB with 1x N2 supplement, and 200µM FUDR & uridine 
(Sigma, St. Louis) 16-20hrs post seed for three days, and then maintained in CB5 
for one week. Cultures were fed three times during this period. DRGN cultures 
were then seeded with either primary, scrambled control, or merlin-KD rat SCs at 
25x103 SCs per well in CB10 medium (CB with 10% HIFBS). One week later, co-
cultures were switched to myelin-permissive medium M-feed (CB with 15% FBS, 
0.05mg/ml L-Ascorbic acid), and fixed 10-14 days later and immunostained. 
 
Immunofluorescence Staining And Imaging 
SC Culture. Following two washes (3min) in PBS on ice, cultures were fixed with 
cold 4% paraformaldehyde in PBS on ice for 10min, permeabilized with 0.1% TX-
100 in PBS for 10min at RT, and blocked for one hour in 10% normal goat serum 
in PBS (Block). Primary antibodies were diluted in Block and cultures were 
incubated at RT for one hour. Cultures were washed 3x for 10min with Block, and 
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secondary antibodies (goat-Alexa Fluor, Invitrogen) were applied for 30min at a 
1:500 dilution in Block. Cultures were washed 3x for 10min with PBS. If applicable, 
DAPI (to stain nuclei) and/or Alexa-633-phalloidin (to stain F-actin) were added to 
the secondary antibody mixture. Finally, cultures were then mounted in Gel Mount 
(ECM Bioscience, CA, USA) and allowed to cure overnight in the dark. Co-
Cultures. Co-cultures were stained similarly to SC-only cultures. Permeabilization 
was done with 0.3% TX-100 in PBS, Block buffer included 0.1% TX-100 which was 
also used for dilution of primary antibodies, and incubation was done overnight at 
4°C. Imaging. All SC cultures were analyzed with a Zeiss LSM710 microscope and 
Zen 2009 software with 40x or 63x objectives. All co-cultures were imaged with a 
RunnerHD (Trophos). Conditions for image acquisition were optimized for each 
secondary antibody in stained cultures on separate channels, and the same 
conditions were used for acquisition of control and experimental cultures. Images 
are either single planes or maximum intensity projections as indicated in the figure 
legends. Analysis. Volocity 6.3 software (Perkin Elmer) was used to measure total 
well fluorescence and individual myelin segments, that were assessed by four 
different parameters:  Mean Pixel Intensity of MBP (amount of MBP in segment; 
total pixel intensity divided by number of pixels in segment), Total Area of Myelin 
Segments (total number of pixels in segment), Shape Factor (a score of roundness 
where 0=straight line and 1=a circle), and Skeletal Length (true length of segment 
regardless of curve). 
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NRG Stimulation And Western Blot Analysis 
SCs were seeded on 200µg/ml PLL-coated 6 well plates (Corning) at a density of 
150-200x103 SCs/well and were grown until 70-80% confluency (72-96hrs) in 
D10M. Cultures were starved of serum and mitogens by rinsing twice in Hank’s 
Balanced Salt Solution (HBSS, Gibco) and incubating in D0.5 (DMEM+P/S+0.5% 
HIFBS) for at least 24 hours prior to treatment. Duplicate wells per condition were 
treated for 30min at 37ºC and 7% CO2 with either D0.5+vehicle (0.2% BSA in PBS, 
“Mock”) or D0.5+30ng/ml NRG1-type III (SMDF, “Stim”). For stimulation in the 
presence of LIMK inhibitor BMS-5, cells were first preincubated with either 5M 
BMS-5 or 0.05% DMSO, and subsequently stimulated in the presence of the drug 
or carrier for 30min at the same concentration. Following treatment, SCs were 
washed twice in cold PBS on ice and were extracted in 200ul (100ul/well) modified 
RIPA buffer+protease/phosphatase inhibitor cocktails (25mM Tris-HCl, ph 7.6, 
150mM NaCl, 1% TX-100, 1% SDS, with 1x PIC, PIC2, PIC3 from Sigma) and 
then separated by SDS-PAGE as follows. 5-10ug of protein (protein concentration 
determined by DC Protein Assay, BioRad) from each lysate was loaded into a well 
of a pre-cast 15-well 4-20% polyacrylamide gels (HEPES buffered, Pierce). 
Proteins were transferred to PVDF membranes (Immobilon®-FL, Millipore). 
Membranes were blocked with a 1:1 Odyssey blocking buffer (Licor) and TBS 
(15.5mM Tris-HCl, 4.58mM Tris, 137.6mM NaCl) for either 1hr at room 
temperature or overnight at 4°C. Membranes were incubated with primary 
antibodies diluted in 1:1 Odyssey Block and TBS-T (TBS with 0.1% Tween-20) for 
either 1hr or overnight at 4°C with agitation. Following three 10 min washes in TBS-
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T, membranes were incubated for 45min with IRDye (either 700 or 800) conjugated 
goat anti-mouse or anti-rabbit secondary antibodies (Licor) at 1:25,000 dilution in 
a 1:1 of Odyssey Block:TBS-TS (TBS-T with 0.02% SDS). Membranes were 
washed three times for 10 min each in TBS-T and quickly at least twice with TBS 
before scanning on a Licor Odyssey imaging system. 
 
Developmental Studies 
Western Blot. Sciatic nerves were isolated from rats at the indicated postnatal 
days, cleaned of extraneous tissue and flash frozen with liquid nitrogen. After 
thawing on ice, they were extracted by homogenizing in a glass tissue grinder in 
RIPA buffer (above) followed by sonication. Extracts were subjected to SDS-PAGE 
and blotted as above. Immunofluorescence Of Teased Sciatic Nerve. Cleaned 
sciatic nerves were fixed by submersion in 4% paraformaldehyde in PBS on ice 
for 30min, rinsed briefly in PBS, and stored at 4°C in PBS. Approximately 0.5mm 
pieces of nerve were carefully teased apart on Superfrost Plus Gold slides 
(ThermoFisher) using Dumont #5CO forceps in PBS. They were allowed to dry for 
6hr-18hr in tissue culture hood, before staining and mounting as described fro 
myelinating co-cultures. Imaging was performed similarly to SC cultures. 
 
 Live Imaging, Motility, And Alignment Assays 
Wild-type (WT), scrambled (SCR), merlin-knock down (MKD) rat SCs were lifted 
by incubation in 0.05% trypsin, labeled with 1µg/ml Hoechst 33342 for 45min at 
37ºC/7% CO2, and then seeded onto purified rat DRG explants grown on PLL 
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(200µg/ml) and Laminin (25µg/ml) coated Mat-tech 12-well plate with 10mm glass 
insert at 5000 cells per insert. They were immediately placed on a Zeiss wide field 
microscope with full incubation control. Three to four hours later, five fields were 
selected for each cell type and images were collected with a Hamamatsu ORCA 
camera every 10 minutes for 24 hours using a 10x phase objective and Zeiss 
AxioVision 4.8.2 software. Volocity 6.3 software (Perkin Elmer) was used to 
manually track cells by selecting the center of the nucleus of cells that remained 
within the field of view for 80% of the duration of the movie. Four parameters were 
measured:  Length (total distance traveled), Velocity (speed along length), 
Displacement (shortest distance between position of cell in first and last frame), 
and the Meandering Index (Displacement/Length). 
 
Statistical Analysis 
Western blots were quantified using Licor Image Studio (v3.0). The integrated 
intensity of similar sized regions of interest for phosphorylated and total proteins 
were obtained and normalized to β-actin signals. All graphs show mean, standard 
error of the mean (SEM), and p-values (see figure legends for specific statistic test 
run) and were calculated using Prism 6 (GraphPad Software, Inc., La Jolla, CA). 
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Results 
Merlin Deficiency In SCs Causes Changes In Morphology, Growth Factor 
Independent Proliferation, And Loss Of Contact Inhibition. 
To investigate the role of merlin during myelination, we transduced primary rat SCs 
with merlin shRNAi to produce merlin knockdown cells (MKD-SC) and compared 
them to wild type (WT-SC) and scrambled shRNAi (SCR-SC) controls (Fig. 16A). 
A proliferation assay was performed over a 72-hour time period in which MKD-SC 
were grown in D10M (DMEM with 10% FBS, and forskolin, and SMDF) or D10 
(DMEM with 10% FBS) (Fig. 16B). WT- and SCR-SC controls were grown in the 
standard D10M medium only. MKD-SC in D10M grew four times faster than control 
cells, whereas those grown in D10 grew at a similar rate as control SCs grown in 
complete medium. This result indicates that MKD-SC proliferation is independent 
of mitogens, but dependent on serum. 
 
Furthermore, we observed that MKD-SC did not exhibit the typical bipolar 
morphology nor “swirling” behavior of normal SCs when they became confluent 
(Fig. 16C). They also lost contact inhibition of growth and formed aggregates 
similar to that of cultured schwannoma cells (Pelton et al., 1998; Zhou et al., 2011). 
At lower cell density they exhibited a phase-neutral, “flat” morphology and attached 
and spread more quickly, similar to cofilin-deficient cells (Sparrow et al., 2012). We 
next examined the expression of standard SC markers by immunofluorescence 
(Fig. 16D). Confocal images indicated that there were no significant changes in 
expression or subcellular localization of GAP43, PLP, P0, O4, Sox10, and YAP 
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except for localization of S100, where it was present in both the nucleus and 
cytosol in SCR-SC but was predominantly expressed in the nucleus in MKD-SCs. 
 
MKD-SCs Overpopulate And Form Short Myelin Segments When Co-cultured 
With Neurons. 
To determine if merlin was necessary for myelination, WT-, SCR-, and MKD-SC 
were co-cultured with disassociated DRG neurons in 96-well plates and then 
grown in myelination-permissive medium for 10-14 days. Co-cultures were fixed 
and immunostained for myelin basic protein (MBP), Neurofilament-heavy chain 
(NF-HC), and DAPI (Fig. 17A). Total well florescence was measured for each 
channel, and the values obtained were normalized to the WT signals (Fig. 17B). 
There was a significant increase in the number of cells in MKD-SC co-cultures, 
indicated by an increase in DAPI signal, compared to controls, but a similar amount 
of both NF-HC and MBP fluorescence. However, if the fluorescence of MBP is 
normalized to that of DAPI, then there is less MBP expression in MKD-SC co-
cultures than controls. 
 
To further characterize myelin formation, regions of interests were drawn around 
individual myelin segments (approximately 55 segments per condition) to assess 
myelin segment length and shape (Fig. 17C). The results indicate that although 
individual segments contained similar amounts of MBP, the myelin segments 
formed by MKD-SC were significantly rounder, shorter, and overall smaller 
compared to segments produced by control SCs. High magnification confocal 
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images of SCR- and MKD-SC co-cultures confirmed the length and shape 
differences in MKD-SC compared to controls (Fig. 17D). These data indicate that 
merlin influences the length of individual myelin segments. 
 
MKD-SCs Migrate And Elongate On Axons, But Do Not Activate Cofilin 
Downstream Of Neuregulin Signaling. 
To investigate why MKD-SC were unable to produce normal myelin segments, we 
first assessed their ability to interact with axons. We tracked motility of Hoechst-
labeled WT-, SCR-, and MKD-SC within the first 24 hours of co-culture with DRG 
neurons, and then categorized their morphology at the end of this period to assess 
their alignment with axons. We measured four motility parameters: the length, 
velocity, displacement, and the meandering Index (Fig. 18A). We found no 
significant differences in any of the parameters between the merlin expressing and 
non-expressing SCs. Therefore, we concluded that the absence of merlin does not 
impair the ability of SCs to migrate along axons. Using the last frame of each 
movie, we categorized the morphology of each cell as either “bipolar”, indicating 
alignment with an axon, or “other” (uni- or multipolar), indicating the cell was 
unaligned with a single axon (Fig. 18B). We found that in each type of cell there 
were approximately 90% aligned, bipolar cells, demonstrating that merlin is not 
needed for SCs to elongate on axons, a prerequisite for myelination. 
 
We previously demonstrated that cofilin’s actin-severing function is activated in 
WT-SCs within 30 minutes of stimulation with neuregulin (NRG) as evidenced by 
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a reduction in pS3-cofilin levels (Sparrow et al., 2012). To test if merlin was 
necessary for activation of cofilin by NRG, we starved sub-confluent WT-, SCR-, 
and MKD-SC of serum and mitogens for 24 hours, and then either mock-stimulated 
or stimulated them with NRG for 30 minutes. Total cell lysates were blotted for total 
and phosphorylated ErbB2 and cofilin (Fig. 18C) to assess the activation of both 
proteins. All SC types increased pY1248-ErbB2 levels in response to NRG 
stimulation; however, the increase in MKD-SC was nearly two-fold above control 
cells. This is consistent with published work that showed a higher expression of 
surface receptors in merlin-deficient SCs compared to WT-SCs (Lallemand et al, 
2009a). Despite this robust stimulation, pS3-cofilin levels in MKD-SC increased 
rather than decreased as expected and observed in both types of control SCs. 
 
To understand why NRG failed to activate cofilin in MKD-SC, we first assessed the 
basal level of  Rac activity in the cells. Rac is both an upstream regulator of cofilin, 
as it causes activation of LIMK via its activation of PAK, and a target of merlin 
regulation (Morrison et al., 2007). In addition, we asked if MKD-SC had higher 
levels of F-actin, the end target in this signaling pathway, that would be consistent 
with an increase in the level of inactive pS3-cofilin (Fig. 18D). We observed an 
increase in both active Rac-GTP and F-actin levels in MKD-SC compared to 
control SCs indicating aberrant regulation of signaling proteins in the NRG-
ErbB2/3-cofilin-actin pathway in the absence of merlin. 
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We hypothesized that the level of active pT508-LIMK would be higher in MKD-SC 
than in control cells based on our observation of increased Rac-GTP and F-actin 
levels, and our previous work that showed increased phosphorylated LIMK in both 
merlin-null cell lines and NF2 paitent samples (Petrilli et al., 2014). Thus, inhibiting 
the LIMK activity at the time of NRG stimulation should lead to dephosphorylation 
and activation of cofilin. Following a 30min pre-incubation with BMS-5, a LIMK1/2 
inhibitor, we stimulated WT-, SCR-, and MKD-SC in the presence of BMS-5 or 
0.05% DMSO (vehicle), and again assessed both pY1248-ErbB2 and pS3-cofilin 
levels (Fig. 18E). Whereas NRG promoted dephosphorylation of cofilin in control 
SCs regardless of LIMK inhibition, NRG promoted dephosphorylation of cofilin in 
MKD-SC only when LIMK was inhibited. This result is consistent with a role for 
merlin in inhibiting LIMK activity to allow cofilin activation in SCs downstream of 
neuregulin signaling. 
 
Merlin, LIMK, SSH, And Cofilin Are Developmentally Regulated. 
We examined the expression and activation levels of merlin, cofilin, LIMK, and 
slingshot phosphatase (SSH) during nerve development. Total protein lysates of 
rat sciatic nerves at postnatal days 1, 5, 15, and 90 were immunoblotted for total 
and phosphorylated proteins (Fig. 19A, B). Over time, total merlin levels remain 
constant, but phosphorylation of the major regulatory residue serine 518, which 
indicates inactivation of the tumor suppressor activity, peaked at postnatal day 15. 
This is the time of active myelination and decreasing SC proliferation. Total and 
phospho-threonine 508 LIMK (active LIMK), as well as total and phospho-serine 3 
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cofilin (inactive cofilin) levels increased over time. There was a near 3-fold increase 
in total LIMK and cofilin, and a 2-fold increase in the percent of pT508-LIMK 
(active), and a 3-fold increase in the percent of pS3-cofilin (inactive). Total SSH 
levels remained consistent, while there was a drastic 40-fold increase in the 
percent of pS978-SSH (inactive) levels. These data indicate that cofilin is active 
during earlier stages of peripheral nerve development when myelination occurs, 
and its activity is inhibited as SCs stabilize their cytoskeleton following myelination. 
 
We also conducted immunofluorescence of teased P1, P15, and P90 rat sciatic 
nerves to spatially localize cofilin in SCs as they mature (Fig. 19C). P15 and P90 
nerves were stained for myelin basic protein (MBP) to reveal mature SCs. The P1 
nerve was immunostained for paxillin as MBP is not present at this time (Fig. 18A). 
Additionally, nerves were immunostained for neurofilament-HC (NF-HC) to reveal 
axons and with DAPI. At P1, cofilin is diffusely distributed in immature SCs 
associated with axons. At P15, cofilin is localized to the adaxonal membrane (inner 
mesaxon). At P90 cofilin is present both at the adaxonal membrane and in 
Schmidt-Lanterman incisures (SLI) in mature, MBP-positive SCs. The location of 
cofilin at the adaxonal membrane is consistent with the hypothesis that cofilin 
participates in promoting motility of the adaxonal membrane around the axon as 
SCs myelinate in response to axonal neuregulin signaling. These data 
demonstrate that cofilin is temporally and spatially regulated during PNS nerve 
development. 
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Discussion 
Cofilin Is Localized To Facilitate Expansion And Wrapping Of The Schwann Cell 
Inner Mesaxon During Myelination. 
Our previous and current study have shown that cofilin is dephosphorylated and 
activated by NRG in SCs (Fig. 18C; Sparrow et al., 2012). Cofilin has been shown 
to be activated by NRG in other cell types as well (Nagato-Ohashi et al., 2004). 
Moreover, we previously showed that NRG causes recruitment of cofilin to the 
plasma membrane and leads to an increase in SC size (Sparrow et al., 2012). Here 
we demonstrate that cofilin is localized to the adaxonal membrane in rat sciatic 
nerves by P15 when active myelination occurs (Fig. 19C). Cofilin may be localized 
to the adaxonal membrane by binding to phosphatidylinositol (4, 5)-trisphosphate 
(PIP2) (Bravo-Cordero et al., 2013), as PIP2 is enriched at the adaxonal 
membrane (Pereia et al., 2011). Binding to PIP2 inhibits cofilin’s severing activity 
and localizes it to the plasma membrane. Both G-protein coupled receptor 
(GPCRs) and RTKs, such as ErbB2/ErbB3, can stimulate phospholipase C 
hydrolysis of PIP2 while cofilin is bound, releasing active cofilin from the plasma 
membrane to enable leading edge protrusion (Yin and Janmey, 2003). 
Furthermore, cofilin becomes hyper-phosphorylated in the sciatic nerve at later 
stages of nerve development (Fig. 19A, B), indicating inhibition of actin severing 
activity in mature nerves. This is consistent with stabilization of the actin 
cytoskeleton once SCs have established a mature sheath around the axon. Hence, 
this evidence supports the hypothesis that cofilin facilitates the expansion and 
 71 
subsequent wrapping of the inner mesaxon during myelination to establish the 
multi-lamellar myelin sheath. 
 
Merlin Indirectly Suppresses LIMK Activity Enabling Neuregulin-Induced Cofilin 
Activation. 
In normal SCs, cofilin is dephosphorylated and activated in response to NRG 
(Sparrow et al., 2012; Fig. 18C). NRG also simultaneously promotes 
dephosphorylation of LIMK and SSH, leading to inactivation and activation of these 
cofilin regulating enzymes, respectively (Sparrow et al., 2012). Furthermore, we 
previously demonstrated that NRG antagonizes PAK activation by stimulating 
dephosphorylation of PAK (Thaxton et al., 2008). Taken together, this regulation 
of upstream signaling molecules would ultimately lead to a decreased pS3-cofilin 
level and increased actin severing needed for cell motility and dynamic changes in 
morphology. 
 
Our results indicated that in the absence of merlin, SC are unable to activate cofilin 
downstream of NRG (Fig. 18C). Merlin is a well characterized suppressor of both 
Rac and PAK (Morrison et al., 2007; Kissil et al., 2003). Indeed, we show that in 
the absence of merlin, basal levels of active Rac and F-actin in SCs are increased 
(Fig. 18D). Thus the normal balance between active and inactive cofilin is disrupted 
in MKD-SC. Specifically, higher amounts of Rac-GTP would lead to active, 
phosphorylated PAK and LIMK, in turn leading to an increase in phosphorylated 
and inactive cofilin, and thus stabilized F-actin. Evidence for hyper-phosphorylated 
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LIMK and cofilin has been published in both mouse merlin null cells and human 
schwannomas (Petrilli et al., 2014). A higher basal level of LIMK activity in MKD-
SC would counteract the ability of NRG to promote dephosphorylation and 
activation of cofilin. The ability of NRG to promote cofilin dephosphorylation in 
MKD-SC treated with BMS-5 is consistent with this conclusion (Fig. 18E). A 
potential signaling pathway by which merlin modulates NRG-ErbB2/3-cofilin 
signaling in SCs to facilitate myelination is presented (Fig. 20). 
 
Merlin Establishes Myelin Segment Length. 
A subpopulation of MKD-SC expressed MBP but formed only shorter myelin 
segments compared to control SC in co-cultures (Fig. 17C). This is in direct 
contrast to SC overexpressing merlin, which we previously showed elaborated 
very long myelin internodes (Thaxton et al., 2008). We propose that the short 
internodes observed in merlin-deficient SCs arise from fewer wraps around the 
axon due to attenuated motility and expansion of the adaxonal membrane because 
of the inability to activate cofilin downstream of NRG. With each wrap, both the 
length and thickness of the myelin sheath incrementally increase. If the expansion 
and motility of the inner mesaxon is abnormal due to dysregulation of cofilin, then 
the myelin internode would be both shorter and thinner than normal. In addition, 
every myelin layer must be anchored to the axolemma at paranodal contacts 
(Salzer 2003). These contacts have been shown to be interrupted in mice with 
conditional inactivation of the Nf2 gene (Denisenko et al., 2008). Therefore, an 
alternative explanation for the short internodes observed in vitro is that the 
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expanding myelin membrane cannot anchor itself to the underlying axolemma in 
the absence of merlin. Our present data cannot definitively distinguish between 
these two possibilities. 
 
In an earlier study, SC hyperplasia subsequent to merlin loss was proposed as a 
possible explanation for the short internodes observed in mice with conditional Nf2 
inactivation (Denisenko et al., 2008). Three types of mutant merlin mice were 
analyzed:  P0-SCH-∆39-121, P0-SCH-∆Cter, and P0Cre;Nf2flox2/flox2. The first two 
mutant strains had a SC-specific overexpression of two dominant negative forms 
of merlin, whereas the last had a SC-specific deletion of merlin. Only the P0Cre; 
Nf2flox2/flox2 (merlin-null) had significantly shorter internodes, even after accounting 
for axon caliber. Similarly, we found both short internodes and SC hyperplasia in 
the MKD-SC/DRG neuron co-cultures. SC hyperplasia was due to the fast 
proliferation rate and mitogen independent growth of MKD-SCs. These findings 
suggest that SC hyperplasia alone is insufficient to cause short internodes and that 
merlin has an additional and separate role in controlling actin dynamics. Support 
for this conclusion is provided by published work that indicates that merlin’s tumor 
suppressor role is separate from its role as an actin cytoskeleton regulator 
(Lallemand et al., 2009b). Overall, the current study suggests that merlin plays an 
essential role in establishing myelin length as it allows for cofilin activation 
downstream of NRG-ErbB2/3 signaling in myelinating SCs. 
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Figures 
 
Figure 16. Primary rat Schwann cells with merlin-KD proliferate independently of 
mitogens, do not contact Inhibit and lose bipolar morphology.  
Primary rat SCs (SCs) were transduced with shRNAi targeting either a random sequence 
(scrambled, or SCR) or merlin mRNA (shRNA-45, or MKD). (A) An immunoblot of total 
cell lysates shows shRNA-45 causes approximately 95% reduction of merlin levels 
compared to wild type (WT) RSCs. (B) Crystal violet growth assay performed over a 72-
hour time period. MKD-SC were grown in either D10M or D10. WT and SCR controls were 
grown in D10M only. MKD-SC in D10M grew four times faster than control cells (n=2, 1 
experiment each using one of two MKD-SC derivations; slopes of linear regression:  
WT=0.0075, SCR=0.0072, 45=0.030). (C) Phase contrast images of all three types of cells 
grown on PLL and in D10M at low and high density. (cell aggregates; arrow). (D) Confocal, 
single-plane, immunofluorescent images of SCR- and MKD-SC grown on PLL in D10M 
for the indicated SC marker proteins. 
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Figure 17. Merlin-KD SCs overpopulate and form short myelin segments in vitro.  
WT-, SCR-, and MKD-SC were co-cultured with purified DRG neurons in ascorbic acid 
containing medium for 2 weeks to induce myelination and immunostained for myelin basic 
protein (MBP), Neurofilament-heavy chain (NF-HC), and DAPI. (A) Images of 
representative wells of myelinating co-cultures. (scale bar=diameter of well=6.39mm) (B) 
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Total well fluorescence for each channel from two independent experiments in which two 
independent MKD-SC derivations and their respective passage matched WT and SCR 
controls were used. Within each experiment 13-14 individual co-cultures were analyzed 
and averaged. The value for SCR- and MKD-SCs are reported as fold change where co-
cultures containing WT-SC were set to one. Fold change values for the two experiments 
were averaged and graphed. (n=2, significance determined by one-way ANOVA, followed 
by Tukey’s post test, *=p-value < 0.05). (C) Using Volocity software individual myelin 
segments were defined from a representative of two experiments, and four different 
parameters were compared:  Mean Pixel Intensity of MBP (amount of MBP in segment), 
Total Area of Myelin Segments, Shape Factor (a score of roundness where 0=straight line 
and 1=a circle), and Skeletal Length. (n=50-58, significance determined by one-way 
ANOVA, followed by Tukey’s post test, *=p-value < 0.05, ***=p-value < 0.001)  (D) Single-
plane, confocal images of SCR- and MKD-SC containing co-cultures confirm the shape 
and length difference between myelinating SCR- and MKD-SC. 
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Figure 18. MKD-SC interact normally with axons, but fail to activate cofilin in response to 
neuregulin stimulation.  
Hoechst labeled WT-, SCR-, MKD-SC were seeded on DRG neurons and imaged with full 
incubation once every 10 minutes for 24 hours. The first frame from a representative 
experiment is shown with 5 tracked cells. Arrowhead indicates direction of cell of 
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movement along the path. Twenty cells, remaining within the field of view for 80% of the 
duration of the movie, for each cell type were tracked. Four parameters were measured:  
Length (total distance traveled), Velocity, Displacement (shortest distance between 
position of cell in first and last frame), and the Meandering Index (Displacement/Length). 
(B) Morphology of 310-350 cells per cell type was assessed as either bipolor (aligned with 
axon) or other (multipolar, or unaligned with axon) approximately 27hrs after seeding on 
neurons. (C) Serum and mitogen starved WT-, SCR-, and MKD-SC were either mock 
stimulated (vehicle; M) or stimulated with NRG (S) for 30 minutes. Lysates were blotted 
for total and phosphorylated ErbB2 and cofilin. Results from three independent 
experiments (two MKD-SC derivations) were normalized to their respective β-actin, 
phosphorylated protein expressed as ratio of total protein, and normalized to mock 
condition. (n=3, significance determined by two-way ANOVA, followed by Tukey’s post 
test;. * p-value < 0.05, ** p-value < 0.01). (D) Confocal, immunofluorescent images of 
SCR- and MKD-SC grown on PLL in D10M for active Rac (Rac-GTP) and F-actin. (E) WT-
, SCR-, and MKD-SC were stimulated similarly to those in (C), but either in the presence 
of the LIMK inhibitor BMS-5 or vehicle (0.05% DMSO), and total cell lysates were blotted 
for total and pS3-cofilin. Measured signals from two independent experiments were 
averaged similarly as in (C) (n=2, significance determined by two-way ANOVA, followed 
by Tukey’s post test;. *** p-value < 0.01). 
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Figure 19. Merlin, LIMK, Cofilin, Slingshot expression and phosphorylation are 
developmentally regulated in peripheral nerves.  
(A) Protein lysates were prepared from sciatic nerves from 1, 5, 15, and 90 day-old rats, 
and blotted for the indicated total and phosphorylated proteins. (B) Quantitation of 
immunoblots is shown (n=2 for LIMK1/p-LIMK1 and SSH1/p-SSH1, n=3 for all others). 
Each signal was normalized to its respective β-actin, phosphorylated protein expressed 
as a ratio of total protein and expressed as fold change from P1 (signal at P1=1). (C) 
Teased P1, P15, and P90 rat sciatic nerves were immunostained for cofilin (red), 
neurofilament-HC (NF-HC; grey), and DAPI. In addition, the P15 and P90 nerves were 
stained for myelin basic protein (MBP; green) and the P1 nerve was stained for paxillin 
(green) (adaxonal membrane; arrows). Images are maximum intensity projections. 
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Figure 20. Model of merlin-regulated, neuregulin-dependent activation of cofilin during SC 
myelination.  
Following basal lamina deposition and polarization of the SC, myelination begins as NRG 
at the adaxonal membrane causes localized activation of cofilin and actin remodeling 
leading to expansion of the inner mesaxon around the axon. Merlin is needed for activation 
of cofilin to occur downstream of NRG signaling. In the absence of merlin, Rac-GTP, p-
LIMK (active), and F-actin levels are all aberrantly high. We propose that merlin inhibits 
LIMK indirectly by inhibiting Rac/Pak during NRG induced activation of cofilin. 
Suppression of these upstream proteins by merlin allows the necessary, and yet to be 
determined (dashed lines), signaling that leads to simultaneous inhibition of LIMK activity 
and stimulation of SSH activity downstream of NRG, which ultimately leads to cofilin 
activation and expansion of the inner mesaxon. In other words, increased LIMK activity in 
the absence of merlin prevents NRG dependent activation of cofilin. Indeed, 
pharmacological inhibition of LIMK allows for cofilin activation following NRG stimulation 
in SCs lacking merlin, and has no effect on cofilin activation in normal SCs. 
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CHAPTER FOUR: GENERAL CONCLUSION 
This thesis has investigated the role of the actin-severing protein cofilin during SC 
development/maturation, specifically during the process of myelination. This is 
novel as there have been no other studies that have examined the specific function 
of an actin depolymerizing protein in SCs. Cofilin is essential to myelination both 
during the alignment and establishment of the one-to-one relationship between the 
SC and the axolemma, as well as in the response to NRG induced membrane 
expansion and wrapping. However, and interestingly, it is not necessary for the 
motility and proliferation of SCs. This result highlights the importance of studying 
individual actin regulating proteins at all SC developmental stages to gain insight 
into how the actin cytoskeleton is regulated during SC myelination, an area that is 
poorly studied yet vital to understand the basic biology of myelinating SCs. 
 
Moreover, this thesis has shown a novel link between cofilin and the NF2 tumor 
suppressor merlin broadening the understanding of the molecular basis of NF2. 
Specifically, merlin is a necessary upstream regulator of cofilin as it permits NRG 
induced cofilin activation by downregulating the activity of LIM kinase in 
myelinating SCs through its negative regulation of Rac and p21-activated kinase. 
This discovery is significant for the NF2 field as it provides further evidence that 
LIM kinase inhibition could be a viable treatment for individuals suffering with NF2, 
a disease with no FDA approved drug therapy, as previously suggested by work 
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published by our laboratory (Petrilli et al., 2014). It should be noted that despite the 
cytotoxic effect of BMS-5 on rat sensory neurons, a new drug could be 
synthesized, perhaps based on the molecular structure of BMS-5, that would still 
inhibit LIM kinase but be harmless to normal tissue. 
 
In addition to the chemical signals from axons and the extra cellular matrix that 
control differentiation of SCs, developing peripheral nerves experience significant 
mechanical stimulation during limb growth. This mechanical stimulation causes 
changes in SC cellular morphology as well as changes in signaling proteins and 
ultimately gene expression. One pathway involved in this mechnotransduction is 
the Hippo signaling pathway (Low et al., 2014). In mammals, two kinases named 
MST and LATS control the activity of two transcriptional co-activators, YAP and 
TAZ, that when present in the nucleus promote proliferation. LATS, downstream 
of external stimuli and MST activation, phosphorylates YAP/TAZ which sequesters 
the co-activators within the cytosol inhibiting proliferation. Signaling through 
junctional complexes, polarity complexes, and G-protein coupled receptors can all 
stimulate LATS dependent phosphorylation. Moreover, the actin cytoskeleton can 
also regulate YAP/TAZ activity through a protein called angiomotin, which inhibits 
YAP/TAZ. Angiomotin associates with F-actin, allowing YAP/TAZ to enter the 
nucleus; however, when F-actin is depolymerized, by cofilin for example, 
angiomotin is free to bind and sequester YAP/TAZ in the cytosol. Recently, a study 
was published that showed YAP/TAZ were essential to Schwann cell development 
(Poitelon et al., 2016). The authors conditionally deleted YAP and TAZ in SC and 
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found that the absence of both of these proteins resulted in server peripheral 
neuropathy due to a deficiency in axonal sorting. This deficiency was caused by 
lack of expression of integrins that are not only critical in the transcriptional 
regulation of developing SCs, but also vital to the normal organization of the ECM 
and overall structure of mature peripheral nerves. 
 
Furthermore, another recent study investigated the role of YAP downstream of 
merlin in the repair capacity of SCs following nerve injury (Mindos et al., 2017). 
After nerve damage, SCs dedifferentiate and undergo rapid demyelination 
transitioning into a repair cell that is dependent upon the expression of the 
transcription factor c-Jun (Jessen and Mirsky, 2016). These reprogrammed SCs 
clear cellular debris, promote axonal regrowth through secretion of neurotropic 
factors, and finally, once axons have regenerated, remyelinate. Mindos et al. 
conditionally knocked out merlin in SCs and observed a similar mild dysmyelination 
phenotype, including hyperplasia and short internodes, as seen in the in vitro 
studies presented in this thesis. However, using nerve crush to model injury, they 
observed that SCs lacking merlin were unable to repair damaged axons as well as 
remyelinate. The reason for this impairment was an upregulation of YAP in merlin-
null SCs. Poitelon et al. reported YAP and TAZ are downregulated in developing 
peripheral nerves. This is not surprising given the fact that SCs must exit the cell 
cycle prior to myelination. Thus, in developing SCs YAP/TAZ could be indirectly 
regulated by cofilin, downstream of merlin, via its regulation of the actin 
cytoskeleton, and links the work of this thesis to these studies. 
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Future in vivo studies to investigate the phenotype of mice with conditional cofilin 
loss in developing SC would be of interest. There are several mouse lines that 
drive expression of Cre recombinase specifically in SCs. These included desert 
hedgehog- (Jaegle et al., 2003) and the P0-Cre lines (Giovannini et al., 2000) that 
have been used to conditionally knock out various genes in SCs, including the Nf2 
gene. A recent publication used a novel Cre line where expression of Cre was 
under the control of the periostin promoter (Gehlhausen et al., 2015). When this 
line was crossed with the Nf2flox2/flox2 line, to produce a conditional knock out of 
merlin in developing SCs, the resulting progeny exhibit a phenotype that more 
accurately recapitulated the symptoms experienced by NF2 patients than previous 
models (Giovannini et al., 1999 and 2000). Specifically, mice produced using this 
periostin-Cre not only developed schwannomas but also exhibited a measureable 
loss of hearing and balance. Mice with a conditional knock out of cofilin in SCs 
could be produced by crossing this Cre driver with a mouse line containing a floxed 
cofilin gene (Gurniak et al., 2005). Based on the in vitro data presented in this 
thesis, it would be expected that these mice would exhibit hypomyelination and an 
associated decreased nerve function. It would be of interest to compare the 
phenotype of these cofilin knockout mice with other reported knockout lines to gain 
further insight into the role of cofilin in developing SCs. 
 
In conclusion, cofilin is the final target downstream of both NRG and laminin 
signaling, two pathways that are vital to the development of myelinating SCs, and 
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merlin regulates this signaling dictating the length of the myelin internode. The data 
presented in this thesis supports the conclusion that the spatiotemporal balance of 
phosphorylated and dephosphorylated cofilin S3 regulates SC function during 
myelination. During axon engagement, an increase in cofilin S3 phosphorylation 
stabilizes F-actin and decreases process motility, allowing for adhesive SC–axon 
interactions to develop. During active myelination, merlin inhibits the activation of 
LIM kinase via inhibition of p21-activated kinase and Rac activation, allowing 
localized dephosphorylation of cofilin S3 at the inner measaxon in response to 
NRG. This signaling leads to remodeling of the cytoskeleton and triggers directed 
expansion of the inner plasma membrane ultimately leading to the production of 
the multilamellar myelin sheath. 
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